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ABSTRACT 
 
LYNNE A. SAMPSON: Screening for syphilis and HIV in North Carolina jails 
(Under the direction of William C. Miller) 
 
 
Sexually transmitted diseases are prevalent among incarcerated populations. 
Screening for STDs in county jails serves as a form of community screening, often 
reaching individuals with poor access to other health care services. The goal of this 
dissertation was to develop and test screening algorithms to improve the effectiveness of 
jail screening for syphilis and human immunodeficiency virus (HIV) infection and to 
examine the costs of adding syphilis screening to existing HIV programs. The studies 
included men and women screened for syphilis (and some also for HIV) in seven North 
Carolina jails in 2002-2005. 
A screening algorithm derived from predictive modeling of new syphilis cases 
can improve screening efficiency for male inmates. Age, race/ethnicity, and reporting an 
STD diagnosis in the last six months were all associated with new syphilis infections. 
When resulting risk scores were applied to hypothetically testing ~50% of the inmate 
population, the algorithm was able to detect 83% of the cases. Women were more likely 
than men to have syphilis (OR 2.5, 95% CI 1.8 – 3.4) but the data did not yield a useful 
predictive model. The prevailing strategy of screening as many women as possible is 
recommended.  
Programmatic and funding changes have resulted in a shift to HIV screening in 
NC jails and new protocols must be designed with HIV as the primary goal. Screening for 
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syphilis under this new paradigm is effective and low cost and should continue. A 
predictive model of HIV infection among jail inmates included age, race/ethnicity, 
gender, history of HIV testing and, for men, men who have sex with men status. Risk 
scores derived from the model yielded screening algorithm with 83% sensitivity for 
detection of HIV when applied to testing ~50% of the population. This same algorithm 
was able to detect 73% of syphilis cases. Using the algorithm for targeted screening 
decreased the cost per HIV case detected from ~$2,200 to ~$1,300. The cost of adding 
syphilis to the existing HIV jail screening program was low (less than $300 per case 
detected) and is recommended in areas with incident syphilis. 
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I. REVIEW OF THE LITERATURE 
 
 
 
 
 
 
 
 
  2 
1.1  INTRODUCTION 
 
Incarcerated populations are at high risk for sexually transmitted diseases (STD)1 
and screening in correctional settings is highly recommended by the Centers for Disease 
Control and Prevention (CDC)2, 3. Jails offer an opportunity for broad impact due to high 
turnover and short durations of stay4, 5. Screening jail inmates at booking serves as a form 
of community screening, often reaching individuals that do not otherwise have contact 
with the health care system. A study of syphilis diagnosis and partner notification found 
that compared to other venues, jail screening identified more ‘high value’ syphilis cases 
with high likelihood of transmission to others6.  
Jail screening for syphilis was implemented in 7 county jails (located in 6 North 
Carolina counties) as part of the CDC Syphilis Elimination Effort (SEE). The program 
was launched in 1999 after CDC found that that over 50% of reported primary and 
secondary syphilis cases in the United States came from just 28 counties7. North Carolina 
has six counties in the project, more than any other state. Since 1999, new case rates in 
North Carolina have declined dramatically, in part due to the success of SEE efforts to 
improve clinical services, surveillance, outbreak response, and community awareness. 
However, an ongoing reservoir of transmission remains and jail screening may play a key 
role in accessing this important group for case detection and treatment.  
Epidemiologic linkages between syphilis and human immunodeficiency virus 
(HIV) have been extensively documented8-16. Syphilis is also posited to increase 
susceptibility to subsequent HIV infection17. Both the CDC and the North Carolina 
Department of Health and Human Services (NC DHHS) recommended that all persons 
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screened for syphilis under SEE programs also be tested for HIV though only two of the 
seven jails chose to do so.  
As of 2007, the CDC still recommended screening jail inmates for syphilis3 
though much of the funding for Syphilis Elimination had been reduced18. At around this 
same time, another division of CDC made sweeping changes to its policies, including 
recommendations for widespread HIV testing in health care settings, including jails and 
prisons19. Many of the jail screening programs formerly funded under SEE are now 
funded as HIV testing projects and new protocols must be designed with HIV as the 
primary objective. 
Personnel and other constraints limit the number of inmates that can be screened 
on any given shift in the jails. It is therefore desirable to focus efforts on those inmates at 
highest risk for testing positive. Any protocols used to determine which inmates to screen 
require not only effectiveness but also ease of use in the jail setting. 
The goal of this dissertation was to use SEE jail surveillance data (2002-2005) to 
describe the prevalence of syphilis, HIV, and associated risk factors in North Carolina jail 
populations and to develop and test screening algorithms to target screening efforts. The 
descriptive information provided can assist prevention programs both within the jail and 
out in the community in identifying and understanding their clients. The algorithms were 
designed to enhance the effectiveness of screening in currently participating jails. An 
assessment of HIV and syphilis screening costs was also done to address the issue of 
adding syphilis to HIV jail screening programs.  
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1.2 SPECIFIC AIMS 
 
The specific aims of this dissertation are as follows: 
 
1.2.1  Aim 1 
 
To (a) examine the prevalence of syphilis and associated risk factors in male and 
female North Carolina jail inmates, (b) develop predictive models for syphilis infection 
based on demographics and self-reported risk factors, and (c) to use the models to 
develop and test a risk score to be used to improve the effectiveness of the jail screening 
program. 
 
1.2.2  Aim 2 
 
To (a) examine the prevalence of syphilis, HIV, syphilis-HIV coinfection, and 
associated risk factors in male and female inmates in two NC jails, (b) develop predictive 
models for infection with HIV and either syphilis or HIV, (c) to use the models to 
develop and test a risk score to be used to improve the effectiveness of the jail screening 
program, and (d) to conduct a cost assessment of the HIV program alone and the 
incremental cost of adding syphilis to an existing HIV screening program. 
 
1.3.  BACKGROUND AND SIGNIFICANCE 
 
1.3.1  The natural history of syphilis  
 
Cases of syphilis can be diagnosed at one of several different stages of infection, 
with differing implications for ongoing disease transmission. Correct diagnosis and 
staging of a syphilis case is an involved process that goes beyond simple laboratory 
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results. It is necessary to understand the complexity of this disease in order to fully 
appreciate the methods of data collection and outcome measures proposed in this study. 
 
Stages of Infection 
 
Syphilis is caused by infection with the bacteria Treponema pallidum. 
Transmission is primarily through sexual contact. It is also remotely possible for syphilis 
to be spread parenterally and all US blood supplies are screened. Transmission via needle 
sharing is thought to be rare20. Pregnant women can also pass the infection to their infants 
in utero resulting in congenital syphilis. 
Untreated syphilis in adults will evolve through a series of stages defined by 
symptoms and duration of time since original infection. Correct diagnosis of these stages 
is critical for understanding the epidemiology of the disease and the potential for ongoing 
transmission. 
The first stage (primary syphilis) is characterized by the presence of one or more 
chancres at the site of infection (usually genital, sometimes oral or anal).  This lesion first 
appears 10 – 90 days after initial infection. The lesion is most often painless and heals in 
a few weeks. Untreated, the disease will then move to the next phase (secondary 
syphilis). The classic symptoms of this stage are a rash on the palms of the hands and 
soles of the feet and enlarged lymph nodes. Other symptoms can include a flu-like 
syndrome (fever, sore throat, malaise), and hair loss (alopecia). Left untreated, these 
symptoms will also resolve within a few weeks. At this point, the patient will become 
asymptomatic. Approximately 25% of untreated patients will relapse into a recurrence of 
secondary symptoms and then return to an asymptomatic state21, 22. Up until the first full 
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year after the initial infection, this asymptomatic (and relapse) period is called early latent 
syphilis. The first three stages combined (primary, secondary, and early latent) are 
together called early syphilis.  
After the first full year of infection, the patient will move into the stage called late 
syphilis. Most patients with late latent syphilis will have no further complications (late 
latent syphilis) but approximately a third will go on to develop tertiary syphilis20, 22. Such 
patients can be in late syphilis for many years without noticeable symptoms. Meanwhile, 
the spirochetes of T. pallidum can invade many different organ systems causing tumor-
like growths called gummas. These may eventually become physically apparent if 
affecting bone, skin, or mucosal tissues. Tertiary syphilis can also be fatal, particularly 
when cardiovascular or nervous tissue has been affected20, 22-26. 
 
Syphilis treatment 
 
Fortunately, syphilis remains relatively simple to treat. Penicillin has remained the 
first line of therapy since the 1940s and no known antibiotic resistance to it has 
developed20, 22, 27. Early syphilis can be effectively treated with a single subcutaneous 
shot of long-acting benzathine penicillin. Late stage patients may require up to three shots 
over a period of three weeks. Patients allergic to penicillin are either sensitized to 
penicillin and then treated or treated with an alternate regimen of doxycycline or 
azithromycin20, 28. Macrolide resistance (to azithromycin) has been detected in at least 
one study20. Penicillin remains the treatment of choice generally and is the only 
recommended treatment for pregnant women20, 28. 
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Sexual transmission of syphilis 
 
During the (approximately) 3-4 week period between initial infection and the 
development of a primary lesion, infected individuals can not transmit syphilis21. Upon 
development of the lesion, patients become infectious to their sexual partners and remain 
so for the entire period of early syphilis (the first year of infection). Transmissibility is 
especially high for the primary and secondary stages and drops off during the early latent 
stage. Identifying and treating early syphilis cases is critical to halt ongoing transmission 
and control outbreaks. When late stage syphilis cases are identified, the primary benefit is 
to the patient who needs treatment to prevent the serious sequelae of late stage syphilis. 
 
Congenital syphilis 
 
Congenital syphilis is an even more serious outcome of adult syphilis infection. 
Many infected infants will die in utero resulting in spontaneous abortion or stillbirth. 
Those born alive can have very serious sequelae including bone and dental abnormalities, 
deafness, and nervous system damage. Women can pass the infection to their infants in 
utero as early as the 9th week of pregnancy. The likelihood of transmission is highest 
when the mother has early syphilis but it is important to note that the infectious period for 
congenital syphilis can last up to 8 years past the date of her initial infection. For this 
reason, finding female syphilis cases at any stage of infection is critical to prevent 
continuing cases of congenital syphilis20, 29. 
 
 8 
Laboratory testing 
 
At this time, most syphilis testing is done with intravenous blood samples. New 
tests that use saliva samples are currently under evaluation but have not entered general 
use30.  When neurosyphilis is suspected, cerebrospinal fluid (CSF) samples may also be 
taken. 
Syphilis testing is done in two steps. The first test is done with a highly sensitive 
non-treponemal assay RPR (Rapid Plasma Reagin) test or a TRUST (Toludine Red 
Unheated Serum Test) and results in a titer (level of dilution at which the assay still reacts 
positively). Titers are from low to high 1:1, 1:2, 1:4, 1:8 … 1:1024, a higher titer 
indicating a greater concentration of antibody in the blood. Initial testing can also be done 
with a more simple test known as a STAT RPR which essentially gives a yes/no reaction 
but no titer. There are a number of factors that can cause these tests to give false-positive 
results including advanced age, other infections, cancer, autoimmune diseases, 
pregnancy, and drug use20, 22. Whether quantitative (titered) or qualitative, initial positive 
tests should be followed by a highly specific confirmatory test.  
Confirmatory testing is done using a treponemal-specific assay, most commonly 
the TP-PA (Treponema pallidum Particle Agglutination) test or MHATP 
(microhemagglutination-Treponema pallidum) test. Under certain conditions, the more 
complicated FTA-ABS (Fluorescent Treponema Antibody Absorption test) may also be 
done and CSF samples are tested using the VDRL (Venereal Disease Research 
Laboratory) test. Any of these tests can eliminate false-positive non-treponemal tests but 
once a person has ever been infected with syphilis, these tests will be positive for life in 
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most cases28. So, if the patient has a documented past history of syphilis, there is little 
point in doing a confirmatory test.  
Patients may exhibit extremely low titers in the first weeks of infection before the 
body has built up an immune response. After that, patients in the early stages will often 
have quite high titers. Successful treatment should cause the titer to drop but for many 
patients, it will never disappear entirely. There are a lot of other factors that can affect the 
titer level so, an individual titer may not be very informative but a titer history on an 
individual patient often is. Importantly, if a patient with a known history of syphilis 
infection and successful treatment is seen to experience a four-fold titer increase (for 
example, 1:4 increasing to 1:16), reinfection should be suspected28. 
 
Stage diagnosis 
 
Syphilis testing and diagnosis are complex. A diagnostic test alone does not 
supply adequate information to accurately diagnose and stage a syphilis case27, 31, 32. Lab 
test results should be followed with a patient interview to determine if and when 
symptoms were present. If the patient is currently experiencing symptoms of primary or 
secondary syphilis, the stage diagnosis is relatively straightforward. However, if the 
patient has progressed to one of the asymptomatic stages, more information is needed. 
Sometimes this approach will not yield results. For example, women often can not recall 
the painless chancre because it was inside the vagina and not visible to them. Recall of 
the classic palmar/plantar rash of secondary syphilis can also be missed when patients 
have particularly dark skin. In such cases, correct staging of a known, infected sexual 
partner may assist in estimating the date of original infection. 
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Thorough patient interviews and partner notification procedures are necessary to 
correctly distinguish early latent syphilis cases (asymptomatic, less than one year from 
infection) from late latent cases (asymptomatic, greater than one year from infection). 
Such policies are not applied equally in all states, making primary and secondary syphilis 
diagnoses the only truly reliable ones for comparative purposes. For this reason, and 
because primary and secondary cases have the highest sexual transmission potential, 
CDC reports that aggregate data to describe national trends or compare states to one 
another focus on primary and secondary syphilis.  The extent of these diagnosis errors 
was documented in a CDC chart review of syphilis reports in six jurisdictions which 
found that half of the reported early latent cases were misclassified. In contrast, over 94% 
of primary and secondary syphilis reports were classified correctly31.  
North Carolina has an excellent system of Disease Intervention Specialists (DIS) 
who provide contact tracing and partner notification for all syphilis and HIV cases in the 
state. The program has exhibited success rates of approximately 98% in locating and 
interviewing suspected cases33. For this reason, confidence in the validity of early latent 
syphilis diagnoses is high and it is appropriate to describe the North Carolina trends in 
terms of ‘early syphilis’ (primary, secondary, and early latent). 
 
1.3.2  Context and history of syphilis  
 
Syphilis is unique among sexually transmitted diseases. It has been well known 
since the late Renaissance period in Western Europe and is the first STD for which 
effective testing and treatment were developed, in the early 20th Century. This long 
history permits archaic perceptions of disease to pervade modern ones. For this reason, 
present-day syphilis carries a stigma and emotional impact not commonly associated with 
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other STDs such as gonorrhea and chlamyidal infection. This unique context affects 
syphilis prevention, detection, and treatment programs including those proposed in this 
study. 
 
Europe 
 
Syphilis as we know it first appeared in Europe around 1495. There remains to 
this day considerable disagreement as to whether or not Columbus brought the disease 
back with him from the New World34, 35 or if the disease was European in origin and 
evolved from a milder form36, or from yaws, which is caused by a similar spirochete35. 
Others have posited that the disease existed far longer and that some Biblical references 
to ‘leprosy’ could be attributed to syphilis34. In either case, the massive troop movements 
associated with a French attack on Naples during 1494 propagated the disease rapidly 
across Europe. By 1498 the disease had spread to India and by 1505 to China35.  
Much of what we know about it today is from the 1530 ‘Poeme de Contagione’ 
which described how the early epidemic took hold and most interestingly, how the 
symptoms seemed to have changed over time from one more characterized by ulcers to 
one predominantly characterized by gummas34, 36. During this early period, there was no 
stigma associated with the disease and special hospitals were created to treat the infected 
with mercury37, despite the fact that venereal spread was well understood34. 
For the next 350 years, syphilis remained in Europe but was often misconceived. 
Doctors mistook gonorrhea for another stage of syphilis20, 22, 34, 38 until the primary, 
secondary and early latent stages were formally described by Ricard in 183720, 22, 38. It 
wasn’t until the end of the 19th century that the complexities of late syphilis and 
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congenital syphilis were finally understood. The spirochete itself was identified by 
German researchers in 1905 and a test to identify infected individuals (the Wasserman 
test) was developed in 190620, though few physicians had access to it in the first years of 
its existence.  
 
United States 
 
Soon after its development, the Wasserman test was put to use for widespread 
testing of soldiers and those about to be married. A survey of US army recruits in 1917 
revealed that 6% were positive for syphilis infection39. The Venereal Disease Division of 
the US Public Health Service was created in 1918 and states began to collect surveillance 
data on cases in the 1930s40. By 1938 twenty-six states had laws that forbade marriage of 
infected persons. That same year, congress passed a bill to provide funding for local 
venereal disease control programs and by the end of 1941 there were over 3000 clinics 
functioning in the US39. During World Wars I and II, the Army conducted massive 
“venereal disease” prevention campaigns that included syphilis testing39.  
In the early 1900s, lengthy, toxic treatments involving mercury, bismuth, and 
arsenic were used with some success39, 41. In 1943 the new drug penicillin was found to 
be effective against both syphilis and gonorrhea20, 38. This development had an enormous 
impact within just a few years; by the end of 1944 the US Army had treated over 100,000 
patients and reported cure rates from 90-97%38.  
The availability of testing and treatment most certainly led to improvements in 
health status of the US population through the treatment of infected individuals and the 
prevention of new cases. However, the military and marriage campaigns of the 1940s 
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may have caused other damage. During the War, syphilis was often portrayed as a 
weapon of the Axis powers: it debilitated soldiers and made them unable to fight and 
when brought home to “pure” American wives and children it destroyed the country’s 
future. This association of syphilis with both moral failure and, indirectly, treason, may 
have contributed to the unique stigma associated with the disease today.  
 
The Tuskegee Syphilis Study 
 
The Tuskegee Syphilis Study began at the crossroads of this time of discovery 
and ended forty years later in scandal. The study began in 1932, prior to the existence of 
an effective cure. The desire of the US Public Health Service researchers was to observe 
the medical outcomes of late stage syphilis. They enrolled 600 African-American 
sharecroppers in Macon, Alabama in their ‘study’. The men were observed without 
treatment, even after it became medically available in 1943. Much was learned about the 
progress of late stage syphilis but at a terrible price. It is estimated that 28-100 men died 
of syphilis throughout the course of the study which finally ended in 1972 when a 
reporter from the Associated Press exposed the study to the media42. A formal apology to 
the men and their families was made by President Clinton in 1997.  
The legacy of the Tuskegee Syphilis Study has been to exacerbate black mistrust 
of public health and other medical personnel. Many wrongly believe that the men in the 
Tuskegee study were purposely infected with syphilis by the government doctors. This 
view is so prevalent that the CDC website addresses the issue directly in the ‘Tuskeegee 
frequently asked questions’ page43. Mistrust of the health care system may prevent some 
infected people from seeking care and may ultimately contribute to ongoing transmission. 
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1.3.3  Context and history of HIV  
 
In stark contrast to syphilis, HIV has a very recent history of high emotions and 
rapid change. As a result, HIV infection is treated differently than any other infectious 
disease in the eyes of politicians, public health officials, and the general public. 
Understanding this context is useful for framing questions posed in this dissertation. 
It is generally accepted that the epidemic “began” in July of 1981 when CDC 
noticed increases in two rare disorders (Kaposi’s sarcoma and pneumocystis carinii 
pneumonia) among gay men in New York and California44. It is now known that there 
were cases of HIV infection dating back to the 1950s but at the time it was brand new. It 
was known as a cluster of symptoms and opportunistic infections and it wasn’t at all clear 
that it was an infectious disease. Many names were used, including GRID (gay-related 
immune deficiency).  
By December of 1981, the acronym ‘GRID’ was already out of date as the first 
cases were reported among injection drug users45. Over the next year, the CDC reported 
cases of the syndrome in Haitians46, hemophiliacs47, transfusion recipients48, and 
newborns49. Reports of a similar disease came in from Europe and Africa as well. In 
September of 1982 the CDC began to refer to the disease as acquired immune deficiency 
syndrome (AIDS)50. Based on the groups affected, an understanding of sexual and 
bloodborne transmission evolved. The discovery of the etiologic agent was several years 
away. 
Working simultaneously, the Pastuer Institute in France51 and the National 
Institutes of Health in the United States52 both reported discovery of the virus that caused 
AIDS. It later became clear that they had both isolated the same virus (LAV to the 
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French, HTLV-3 to the Americans). Human immunodeficiency virus (HIV) was a name 
proposed in 1986 to resolve the dispute between the two laboratories53.  
The first breakthrough for AIDS patients came in 1987 with the announcement 
that an old cancer drug azidothymidine (AZT) was effective in warding off some of the 
opportunistic infections in AIDS patients54. For many, the victory was short-lived as the 
virus developed resistance to the drug. A 1994 study showing that AZT might be 
effective in reducing mother to child transmission was welcome news55. A series of other 
more effective drugs were introduced in the coming years and US AIDS deaths declined 
in 1996, the first decline since reporting began56. 
Throughout this early period, there was a great deal of fear surrounding the new 
disease. New risk groups were constantly being identified and the precise modes of 
transmission were not clear. Gay men and Haitians of all sexual persuasions were banned 
from donating blood. Infected health care workers faced discrimination in the workplace. 
In 1985, thirteen year-old Ryan White was banned from attending school in Indiana57. 
AIDS was also added to the list of diseases for which immigrants could be barred entry to 
the United States. In protest, the International AIDS Society (IAS) moved its 1990 
conference from Boston to Amsterdam and has not held a conference on US soil since58. 
The AIDS community, largely gay men, responded to this environment with strength and 
organization. Groups such as ACT UP (AIDS Coalition to Unleash Power) brought 
recognition to issues as diverse as drug company price gouging and federal policy 
regarding funding for needle exchange programs.  
The tone of these early years has had lasting effects on HIV policies in the United 
States. Fear of discrimination has meant that today HIV information is afforded levels of 
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security well beyond those for other infectious diseases. This fact is well illustrated by 
the surveillance data. At first, the disease was classified as a syndrome (AIDS). Later, 
when antibody testing became available, activists were concerned about the possibility of 
health departments having a list of everyone with HIV and fought for anonymous testing.  
States with this policy might know how many positive tests were done in a given year but 
could not calculate any true prevalence rates because there was no way of knowing how 
many of the tests were duplicates.  
CDC issued recommendations in 199956 and 200559 urging states to move toward 
name-based reporting. As of the July 2005 letter, all states had moved to some form of 
HIV reporting but 14 were of limited value nationally because they were not name-based. 
The list included states with some of the largest cities, and presumably, the most 
organized activists: California, Illinois, Massachusetts, New York, Oregon, Washington. 
As of April, 2008, all 50 states had finally adopted the same name-based reporting 
scheme60. The fact that it took over 20 years to get all states reporting a brand new, 
invariably fatal disease is quite extraordinary and illustrates the social complexity of 
HIV. 
 
1.3.4  Current epidemiology of syphilis  
 
Syphilis in the United States  
 
With widespread use of penicillin, US primary and secondary syphilis rates 
declined dramatically from over 500 cases per 100,000 population in 1945 to less than 
150 cases per 100,000 in 195561. Rates continued to decline through the mid 1970s (to 
around 10/100,000). In the mid 1980s rates began to climb again in an outbreak 
associated with the twin epidemics of HIV and crack cocaine62. This epidemic peaked in 
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1990 with 20.3 cases of primary and secondary syphilis per 100,000 population7. By 
2000, national P&S syphilis rates had declined to the lowest ever recorded since 1941 
(2.2/100,000 population)61. Since that year, overall rates have increased slightly each year 
from 2001 to 200463. These increases have been associated with documented outbreaks of 
syphilis among men who have sex with men in a number of US cities64, 65. 
Congenital syphilis rates generally follow the pattern of early syphilis rates 
among adult females. In recent years, US congenital syphilis rates peaked in 1991 (107.3 
cases/100,000 live births), one year after the highest adult rates, and have been declining 
steadily since to 8.8 in 200463. 
Syphilis epidemiology is marked by inequalities of age, race, gender, and 
geography. Within the US, syphilis rates in the South (AL, AR, DC, DE, FL, GA, KY, 
LA, MD, MS, NC, OK, SC, TN, TX, VA, WV) have long exceeded those in other areas 
of the country63, 66. The region reported 48% of all US primary and secondary syphilis 
cases in 200463. In the last 20 years, the Southern P&S syphilis rate peaked in 1990 at 
around 33 cases/100,000 population. Since that year, gaps between the regions have 
narrowed and rates in all regions declined until 2001 when rates began to rise again.  
The highest P&S rates are currently reported among males in the 35-39 year-old 
age group (12.4/100,000 in 2004) and among younger females age 20-24 (3.0/100,000 in 
2004)63. This gender disparity is indicative of long-term trends of higher male rates. 
Throughout the 1980s the gap between them was fairly wide (around 2-3 times higher). 
As rates for both genders declined after 1990, the gap narrowed to a low of 1.2 times 
higher in 199667. Since then, the gender disparity has increased, driven by outbreaks 
among MSM in several cities (Figure 1). In some of the most affected cities, the 2004 
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male to female rate ratios are dramatic (181.4 in San Francisco, 40.5 in St. Petersburg, 
FL) while in other areas, the epidemic appears to be largely heterosexual (1.3 in 
Albuquerque, Newark, and Jacksonville, FL)67.  
Severe racial disparities mark the most dramatic and disturbing trend in US 
syphilis epidemiology (Figure 2). When national P&S syphilis rates peaked in 1990, rates 
among non-Hispanic blacks were approximately 50 times higher than the rates among 
non-Hispanic whites67. Rates for other racial minorities were also higher than those for 
non-Hispanic whites but to a far lesser degree. In the following years, rates among all 
racial and ethnic groups followed overall trends of decline through 2000 and then slight 
increases. In 2004 the black P&S syphilis rate was 5.6 times higher than that for non-
Hispanic whites, a great improvement but a still unacceptable ratio67.  
Grassly and colleagues have developed a model based on host immunity responses to 
explain the periodic rise and fall of US primary and secondary syphilis rates68. However, 
this model assumes that the same populations are at risk over time. A more stratified 
analysis reveals that syphilis peaks in 1982, 1990, and 2000 involved very different 
subpopulations64. Concurrent HIV epidemics have also been an important factor both in 
facilitating transmission and in decreasing the number of susceptibles15. 
 
Syphilis in North Carolina  
 
North Carolina is a state disproportionately affected by syphilis. When the 
primary & secondary syphilis rate peaked in North Carolina in 1992, it was nearly three 
times higher than the national rate that year (36.2 vs. 13.3/100,000)69. From 1993-2003, 
North Carolina ranked in the top 10 states in primary and secondary syphilis rates and in  
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Figure 1.1: Primary and secondary syphilis – Rates by sex: United States, 1981-2004 
and the Healthy People 2010 target 
 
 
Note: The Healthy People 2010 target for P&S syphilis is 0.2 case per 100,000 
population. 
Source: CDC STD Surveillance Report, 200463 
 
 
 
 
Figure 1.2: Primary and secondary syphilis – Rates by race and ethnicity: United 
States, 1981-2004 and the Healthy People 2010 target 
 
 
Note: The Healthy People 2010 target for P&S syphilis is 0.2 case per 100,000 
population. 
Source: CDC STD Surveillance Report, 200463 
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 the top 20 for congenital syphilis rates. In 2003 North Carolina dropped to a rank of 19th 
among states with a primary and secondary syphilis rate of 1.8/100,000 with n=152 cases 
reported70. That rate has since increased to 3.6 for 2006 and a slightly higher rank of 12th 
with n=309 cases reported71.  
Within the state, the demography of early syphilis cases (primary, secondary, and 
early latent) was often distinct from the national trends. From 2002-2006, early syphilis 
cases were most frequently reported among 20-39 year-old males and females72. Since 
1990, the male to female ratio of early syphilis cases remained close to one for more than 
a decade, evidence of a largely heterosexual epidemic72. While the number of cases 
among both men and women declined each year from 2000-2003, the ratio of males to 
females rose steadily from 1.0 in 2000 to 1.5 in 2003. The number of early syphilis cases 
reported among men began to increase in 2004 and MSM outbreaks in several cities were 
identified72.  Cases among women rose in 2006.  
Syphilis also disproportionately affects minority populations in North Carolina. 
The vast majority of early syphilis cases were among non-Hispanic blacks 
(approximately 70% per year, 2000-2006) though they make up only 22% of the State’s 
population. Racial disparity among men has generally declined in recent years. An 
outbreak in 2001 caused a spike in Native American cases that year but otherwise, the 
general trend for all racial and ethnic groups has been declining early syphilis rates from 
2000-2004. Rates for black non-Hispanic and Hispanic males began to increase again in 
2004. Black males suffer the greatest disparity with a 2000 early syphilis rate of 
50.5/100,000, 21 times higher than the non-Hispanic white rate for that year. This 
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disparity narrowed to 7 times higher in 2006. Hispanic disparity dropped from 9 to 2 
times higher than white rates72.  
For women, early syphilis rates for all racial and ethnic groups are falling but the 
disparity between the races is increasing because the white rates are dropping the fastest. 
During the 2001 outbreak, the Native American women actually experienced rates more 
than 30 times higher than the white rates but the current disparity is just 2 times higher. 
Black disparity increased from 9 to 17 and for Hispanics the increase was from 4 to 9 
times higher72.  
 
1.3.5  Current epidemiology of HIV  
 
HIV in the United States  
 
National trends in HIV infection have been difficult to assess. In the early years of 
the epidemic, the only data available were for AIDS cases. At that time, no treatments 
were available so progression to AIDS was much more rapid and certain. Still, AIDS data 
was not really ideal for estimating the incidence of new HIV infections because there was 
a delay between infection and AIDS. In the late 1990s, new treatments dramatically 
slowed progression of disease, making the use of AIDS data to estimate HIV incidence 
even more problematic. Through 2007, AIDS cases were the only measure that had been 
consistently reported for all 50 states60. The Ryan White Care Act used AIDS cases to 
allocate funding until a 2006 reauthorization incorportated HIV infection data for the first 
time73.  
By the end of 1988, over 82,000 cases of AIDS had been reported to CDC, 91% 
of them among men74. The majority of these were white MSM75. About 70% of cases 
among heterosexual men, women, and children were of black or Hispanic race/ethnicity.  
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For women, injection drug use (either the patient or a sex partner) was associated with 
half of white AIDS cases and three quarters of black and Hispanic cases75. At this time in 
1988, nearly all patients died within five years of their AIDS diagnosis. AIDS was 
responsible for 10% of all deaths among US men age 25-44 and 2% of all deaths for 
women age 25-4474. 
Ten years later, the epidemic had grown in both size and scope. By this time, 
there were effective treatments available for HIV infection, prolonging progression to 
AIDS and death. AIDS reports began to represent failures of public health; HIV 
infections that should have been identified and patients that should have been treated 
before developing AIDS. Over 44,000 cases of AIDS were reported in 1998 alone and 
nearly a quarter of them were among women76. For men, MSM remained the highest risk 
factor (53%), followed by IDU (27%). The majority of female cases (61%) were 
attributed to heterosexual transmission while only 12% of male cases had that risk. Racial 
disparities grew; only 36% of male and 17% of female cases were among whites76. 
More recent data indicate that the distribution of AIDS cases seen in 1998 is 
largely repeated in 2006. There were over 36,000 cases reported that year and about a 
quarter of them were female77. Heterosexual transmission was the highest risk factor for 
women (73%) followed by injection drug use (24%). Among men, slightly more cases 
were attributed to MSM (59%) and heterosexual transmission (17%) and less to IDU 
(16%)77.  
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HIV in North Carolina 
 
Name-based reporting of HIV infection has been required by law in North 
Carolina since 199072. Anonymous HIV testing was discontinued in 1997 which means 
that the reporting data from 1998 forward theoretically includes all persons diagnosed 
with HIV. This discussion of HIV infection in North Carolina will use the measure ‘HIV 
disease’ which is the first report of HIV infection for an individual, regardless of stage of 
infection (HIV infection only or HIV infection and meeting AIDS case diagnosis 
criteria).  
New HIV disease reports in North Carolina were at their peak from 1992-1995, 
averaging over 2000 reports per year. This same period also had the highest number of 
syphilis case reports and the highest HIV prevalence found in the Survey of Childbearing 
Women72.  HIV disease reports dropped below 1500 per year in the late 1990s, rising 
again in 2001. Currently about 1700 new cases are reported each year. Of these new HIV 
reports, about 30% are new AIDS cases which indicates lost opportunities for screening.  
HIV disease reports in NC have consistently been the highest among persons age 
30-4972.  A recently identified outbreak among college students in the state has brought 
new attention to the disease in younger age groups78. The North Carolina epidemic is also 
marked by substantial racial disparities. In 2006, 66% of HIV disease cases were reported 
among non-Hispanic blacks though they make up only 22% of the state population72. 
Hispanics represented 8% of HIV cases and just 6% of the population. 
Among men, the largest number of HIV disease cases reported in 2006 were 
attributed to MSM activity (69%) and most of the rest to heterosexual sex (24%). North 
Carolina differs from the national AIDS data in that the proportion of cases associated 
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with injection drug use is very low. Among men only 4% were IDU and 2% 
MSM/IDU72, compared to 18% and 5% in the CDC AIDS data77. For women only 11% 
of NC cases were associated with IDU compared to 24% of national AIDS cases. The 
HIV epidemic in North Carolina women is almost exclusively connected to heterosexual 
sex (86%).  
 
1.3.6  Twin epidemics of syphilis and HIV  
 
Epidemiology 
 
It would seem obvious that individuals at risk for one sexually transmitted disease 
would be at risk for another STD because the same risk behavior (unprotected sex) is 
associated with both infections. These joint risks, however, are not equally distributed 
among populations and it has been long understood that certain STDs tend to ‘travel’ 
more often together. Since the earliest days of the HIV epidemic in the US, syphilis has 
been associated with HIV. Studies of HIV-infected populations have documented high 
rates of incident syphilis infection16, 79 and syphilis studies have established HIV 
infection as a consistent risk factor9, 10, 12, 13. Likewise, other studies have shown syphilis 
to be a predictor of HIV infection8, 11, 14. 
To a certain extent, the association of these two epidemics is a function of the 
similar sexual networks in which the diseases happen to travel. Biologic explanations 
have also been documented. Fleming and Wasserheit’s comprehensive review formally 
established the association between sexually transmitted infections and ongoing HIV 
transmission. Their case was strongest for the ulcerative STDs (syphilis, chancroid) in 
which the STD both increases infectiousness (viral shedding) and susceptibility17. Studies 
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of syphilis biology reveal that the same immune cells that are most sucsceptible to 
infection by HIV were found in high concentrations at the site of syphilis lesions22. 
 
Risk Behaviors  
 
Syphilis and HIV cases come from a similar group of susceptible individuals. 
Despite the reports of recent outbreaks among men who have sex with men64, 65, sexual 
networks that include drug users, incarcerated populations, and those who trade sex 
remain an important reservoir of syphilis infection. Case-control studies in US STD 
clinics (using non-syphilis patients as controls) have found syphilis to be associated with 
trading sex for drugs or money80, 81, reporting a greater number of sex partners12, 80, 81, use 
of crack or cocaine80, 81, and reporting a history of incarceration12. Other US case-control 
studies that used reported cases of adult syphilis82 or congenital syphilis83, 84 and 
community-based controls found associations with trading sex for drugs or money82, 
reporting more partners82, and use of cocaine83, 84. A cohort study of street-recruited 
injection drug users in Los Angeles also found incident syphilis infection to be associated 
with trading sex for drugs or money, reporting a greater number of partners, crack 
smoking, and cocaine injection (as opposed to injection of other drugs in this IDU 
population)85. A behavioral survey of female detainees in Chicago found that 32.5% 
report trading sex for drugs or money and 18.8% reported injection drug use86. These 
risks are themselves linked as prostitution and drug possession/sale are among the most 
common reasons for arrest87. 
Surveillance data for HIV infection are painstakingly collected and already 
include a behavioral risk component. Injection drug use, heterosexual sex with high risk 
 26 
partners, and for men, MSM sex have all been identified as high risk activities. Other 
behavioral studies have found that like syphilis, HIV has also consistently been 
associated with trading sex for drugs or money88, illicit drug use11, 14, 88, and history of 
incarceration11, 14.   
 
1.3.7  Syphilis and HIV in incarcerated populations 
 
Jails and prisons 
 
Because both syphilis and HIV are highly prevalent in incarcerated populations, 
numerous screening programs to detect new infections have been proposed and/or 
implemented in jails and prisons across the US. It is very important to distinguish the 
difference between these two types of institutions and the purpose of screening in each. It 
is also important to note that some states and localities operate correctional systems that 
combine jail and prison into one facility. North Carolina is one of 44 states that maintains 
separate jail and prison systems89. 
Jails are locally operated (city or county) and serve to house persons arrested and 
awaiting trial and those sentenced to short terms of generally less than one year. The 
average inmate stays in jail for less than two days4, most posting bond and awaiting trial 
outside jail. Others remain in custody longer because they are unable to post bond or a 
judge has required that the individual await trial under custody. A much smaller 
proportion of inmates are sentenced to short terms (less than one year) and serve their 
time in the local jail. Those sentenced to longer terms would be transferred to a prison 
under state or federal jurisdiction. In North Carolina, only about 23% of the jail 
population at any given time are serving sentences; the remainder are pretrial detainees90. 
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Because most inmates are housed for only a matter of days, conditions are 
crowded and opportunities for inmate recreation are limited, decreasing the opportunities 
for sexual contact (and ongoing transmission) within the institution.  In many cases, the 
screened inmate will have been released long before screening test results have returned 
from the lab. In such settings, STD screening programs serve as community-level 
screenings, reaching a population that often has limited contact with other health care 
services and screening opportunities.  
Prisons are generally under state or federal control and are designed to house 
inmates sentenced to terms of one year or longer. Essentially all prison inmates will have 
spent some time in jail before trial, sentencing, and finally entering prison. Screening for 
STDs in this setting has very different functions: to maintain the health of the inmate 
population while they are in custody and prevent ongoing transmission within the facility. 
 
Screening incarcerated populations for syphilis 
 
Syphilis screening programs have been implemented in prisons and jails and have 
consistently found syphilis rates many times higher than the general population. Studies 
of female inmates have found syphilis prevalences ranging from 1.4-22.2%8, 13, 14, 82, 91-99 
while male screening finds prevalences from 0.6%-5.7%8, 11, 92-95, 98, 100, 101. Several 
studies that did not stratify results by gender found 0.1-2.0% syphilis prevalence102-104. 
The number of cases detected through screening will be affected by the level of disease in 
the communities from which the inmates arise and screening and control practices there. 
However, studies that include both male and female inmates have consistently found 
higher syphilis prevalence among women8, 92-95, 98. 
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Another reason for the width of these ranges is the wide variety of syphilis case 
definitions used. As previously described, syphilis case diagnosis is complex and requires 
titer history, treatment history, and patient interview in order to be complete. Table 1.1 
describes some of the case definitions used in increasing order of completeness. For a 
detailed summary of syphilis screening studies in US incarcerated adults, please see 
Appendix A. 
As stated above, female inmates consistently show higher prevalence of syphilis 
than their male counterparts. Syphilis is also more likely to be detected in inmates in 
older age groups (≥ age 30)91-94, 101 and among those of Black91, 93, 94, 98, 101, 104 or 
Hispanic94, 101 race-ethnicity. One study also reported an association with low 
education101 and another with unmarried status98. 
Only a small number of studies directly assess the relationship between arrest 
charges and syphilis outcome. Cohen and colleagues found no association in their study 
of male arrestees in Los Angeles while Beltrami et al found a weak association with 
misdemeanor (vs. felony) status in New Orleans98. Felony theft charges were found to 
predict syphilis case status for male inmates in one study93. Among females, charges 
related to drugs13 and prostitution13, 93 were significant. Less directly, Farley and 
colleagues found high numbers of syphilis cases among women incarcerated for 
prostitution (10%) and drug charges (7%)82 and Blank et al documented a high rate 
(8.1%) of incident syphilis among recidivist female inmates in New York City96.  
Even fewer studies collected data related to behavioral risk and made direct 
comparisons to syphilis status. Past history of STD was predictive of syphilis for both 
males101 and females13. History of injection drug use was associated with female 
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Table 1.1: Case Definitions used in Syphilis Screening Studies 
 
Case Definition Studies used 
Screen test +, Confirmatory test + (Altice 2005)14, (Solomon 2004)102,  
(Altice 1998)11, (Beltrami 1997)98,  
(Bickell 1991)99, (Weisfuse 1991)8 
Screen test with high titer (≥1:8) (Finelli 2002)92, (Mertz 2002)94 
Screen test with high titer (≥1:8), 
Confirmatory test + 
(De Ravello 2005)91 
Screen test +, Confirmatory test + if 
negative at baseline,  
Screen test + with 4-fold titer increase if 
positive at baseline 
(Blank 1999)96 
Screen test +, Confirmatory test +, 
Treatment history if available 
(Kahn 2002)93, (Rich 2001)13,  
(Silberstein 2000)95, (Blank 1997)97,  
(Farley 1990)82 
Full case diagnosis and staging: Screen test 
+, Confirmatory test +, Treatment history, 
Patient interview, Staging 
(Chen 2002)100, (Heimberger 1993)104,  
(Cohen 1992)101 
 
syphilis13 while history of cocaine use and reporting ≥3 sex partners in the last 90 days 
were associated with male cases101.  
 
Screening incarcerated populations for HIV 
 
Like syphilis, HIV is highly concentrated in incarcerated populations and 
screening programs have been implemented to improve case detection in correctional 
settings. HIV prevalences for male inmates range from 0.8-16.1%8, 11, 100, 105-108 and for 
females from 1.0-25.8% 8, 14, 91, 106-108. Studies that did not stratify by gender found 
prevalences from 2.3% to 16.8%102, 103, 109. Studies that included data for both males and 
females found consistently higher prevalence of HIV infection among females8, 106-108. 
The factors associated with HIV infection in incarcerated populations are similar 
to those for syphilis. Higher prevalences have been found among those in older age 
groups11, 14, 91, 105, 107 and among those of Black11, 14, 91, 103, 105, 107 or Hispanic8, 11, 14, 105 
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race-ethnicity. None of the reviewed studies directly assessed the relationship between 
arrest charges and HIV status. 
A limited number of studies examined the associations between risk behaviors 
and HIV infection. Men who reported sex with other men, either with or without IDU 
were at increased risk for HIV infection108. Injection drug use was identified as a risk 
factor among males11, 105, 106, 108, females14, 106, and mixed gender populations107. Heroin 
use was also associated with both male and female HIV infection8. Altice and colleagues 
found use of crack cocaine and history of any STD associated with infection in males11. 
The same group also found non-injection drug use, commercial sex work, and recidivism 
associated with HIV in females14. 
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2.1.  PRELIMINARY STUDIES  
 
2.1.1  The Syphilis Elimination Effort 
 
In 1995, the CDC convened a meeting of experts and researchers to discuss the 
issue of persistent high rates of syphilis in the southeastern United States in an era when 
US rates were declining to all time lows1. Over the next several years, much work was 
done and numerous articles published describing the ways in which syphilis had become 
highly concentrated in the US1-5 and discussing issues in syphilis control6-12. The CDC 
examined 1998 data and determined that over 50% of all U.S. primary and secondary 
(P&S) syphilis cases were reported from just 28 counties. This concentration of disease 
and the fact that rates were at all-time lows provided an opportunity for the possible 
elimination of U.S. syphilis transmission. The disease has no animal reservoirs and 
identification and treatment of all early cases can effectively halt ongoing transmission. 
In October of 1999, CDC announced the beginning of The Syphilis Elimination Effort 
(SEE) which provided funding to the 28 high-morbidity areas (HMAs) for enhancements 
in surveillance, outbreak response, clinical and laboratory services, health promotion and 
community involvement13. 
 
2.1.2  Syphilis Elimination in North Carolina 
 
North Carolina was a unique and important player in the Syphilis Elimination 
Effort. It had more SEE counties than any other state (five) and unlike the majority of 
SEE counties in other states, several in NC were rural or had only small cities. The State 
of North Carolina received extra funding to prevent syphilis in these counties. The 
HIV/STD Prevention and Care Branch in the North Carolina Division of Public Health 
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coordinated many of the SEE activities and had several CDC assignees designated to the 
project. The team determined that a 6th county (Durham) should be included in the SEE 
work because syphilis was a significant problem there, even though it did not make the 
CDC list of 28. Table 2.1 shows the P&S syphilis rates in these counties and places them 
in context with the state and US as a whole. 
The CDC also provided extra funding (above and beyond the regular SEE 
funding) to 3 counties as demonstration sites for Syphilis Elimination. These included 
Marion County, IN (Indianapolis), Davidson County, TN (Nashville) and Wake County, 
NC (Raleigh). 
As part of the enhanced surveillance component of Syphilis Elimination, screening for 
syphilis in jail populations was recommended by CDC. Four of the six SEE counties 
began screening early on in their Syphilis Elimination activities. However, little 
information was collected to further the objective of enhanced surveillance. 
Modifications were made to the existing testing protocols in 2002 and new jails were 
added to the project. As of the fall of 2002, seven jails in the cities listed in Table 2.2 
were participating in the project. Screening personnel in the jails provided counseling and 
education on syphilis and other STDs, collected risk factor information from the inmates, 
and drew blood for screening. 
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Table 2.1: Primary and Secondary Syphilis Cases and Rates, North Carolina, US, 
2000-4 
Location 2000 2004 
 Cases Rate/100,000 
pop 
Cases Rate/100,000 
pop 
DURHAM 18 8.0 12 5.1 
FORSYTH 24 7.8 3 0.9 
GUILFORD 69 16.3 38 8.8 
MECKLENBURG 45 6.4 40 5.3 
ROBESON 58 47.0 16 12.7 
WAKE 32 5.1 20 2.9 
     
All NC 483 6.0 
state rank = 2 
193 2.3 
state rank = 15 
     
All US 5,979 2.1 7,980 2.7 
Sources: NC HIV/STD Surveillance Report 2004, CDC STD Surveillance Report 2004 
 
 
 
Table 2.2: North Carolina Syphilis Elimination Effort Counties and Major Cities 
 
County Primary City City Population 
(Census 2000) 
County Population 
(Census 2000) 
DURHAM Durham 187,035 223,314 
FORSYTH Winston-Salem 185,776 306,067 
GUILFORD Greensboro 223,891 421,048 
 High Point 85,839  
MECKLENBURG Charlotte 540,828 695,454 
ROBESON Lumberton 20,795 123,339 
WAKE Raleigh 276,093 627,846 
Source: North Carolina State Center for Health Statistics 
2.2.  Research Design and Methods 
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2.2.  RESEARCH DESIGN AND METHODS 
 
2.2.1  Project Description 
 
Goals and Rationale for Jail Screening Evaluation 
 
Both the North Carolina HIV/STD Prevention and Care Branch leadership and 
Syphilis Elimination partners at CDC were very interested in evaluating all aspects of 
SEE activities, including jail screening. One of the primary objectives of the jail 
screening program was to monitor the prevalence of syphilis in the jails as part of 
enhanced surveillance. In this sense, jail detainees serve as a sentinel population which 
may provide early warning regarding new outbreaks of syphilis in the community. 
Another goal of the evaluation was to directly assess the role of jail screening in syphilis 
case detection. Assuming that jail screening is deemed valuable with respect to both 
 surveillance and case detection, a final objective of the project was to use the collected 
data to inform and guide future screening efforts as syphilis rates decline and the need for 
more targeted screening is warranted. To this end, the first aim of this dissertation was to 
develop screening algorithms for targeted syphilis screening.  
In the years since Syphilis Elimination began, the funding climate has changed 
with important consequences for the jail screening program. In the past two years, the 
funding for SEE has been cut dramatically14 but the recommendation to screen jail 
inmates for syphilis remains intact15.  Meanwhile, the HIV Division of CDC announced a 
series of new recommendations, including screening for HIV in jails and prisons16. The 
end result has been that NC has been able to keep most of the former SEE jail screening 
programs in operation by converting them to HIV testing programs. The second aim of 
this dissertation was changed from a syphilis-centered study to the development of HIV 
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testing algorithms and examination of the addition of syphilis screening to HIV testing 
programs in the jails. 
 
2.2.2  Study Population 
 
All inmates entering NC jails (n=102)17 are assessed upon entry (within the first 
hours of arrival) for wounds or other medical conditions requiring immediate attention. 
This inquiry includes major chronic illnesses that require treatment (such as diabetes) and 
infectious diseases such as tuberculosis that might pose a danger to other inmates or jail 
staff.  Since most jail inmates have a very short duration of stay in the facility, medical 
screening of inmates at this stage is generally minimal and confined to immediate 
concerns. Approximately half will bond out in the first 48 hours and many others will do 
so in the first two weeks. Once an inmate has been in the facility for a full two weeks, the 
focus of the jail medical staff shifts. At this point it is likely that the inmate will be in the 
jail for a longer stay and the focus of medical attention shifts from short term to long-
term concerns. Inmates undergo a thorough medical evaluation called “14-day physical” 
which includes screening tests for a number of diseases. These differ by jail but most of 
the time this includes syphilis screening. 
The Syphilis Elimination jail screening project (n=7 jails) was intended as a form 
of community screening and aimed to reach the large number of inmates that would not 
be accessed through the 14-day screening process. Ideally, the goal was to reach inmates 
in the first 24-48 hours before they posted bond. Whenever possible, the screening took 
place at or near the intake area of the jail which provided access to inmates very shortly 
after their arrival and often before they had been assigned to a cell. The physical layout of 
the jail and the availability of correctional staff to provide security determined whether or 
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not this was feasible. If not, the screening sometimes took place in the housing areas of 
the jail. In these situations, the program was generally screening inmates who had been in 
the facility longer than a day but shorter than two weeks.  
The screening program included both male and female inmates. At this point there 
were no guidelines used to determine who would be screened. However, due to the 
importance of screening women to prevent congenital syphilis, SEE staff were advised to 
screen as many female inmates as possible. 
 
2.2.3  Data Collection 
 
Syphilis data collection form 
 
North Carolina began receiving Syphilis Elimination funding in 1999 and by the 
spring of 2001 four jails had begun syphilis screening programs (Durham, Forsyth, 
Robeson, and Wake). The SEE staff working at each jail developed their own data 
collection forms. Two sites collected only demographic information while the other two 
opted to collect risk factor information. Examination found that the risk information was 
inadequately designed, not systematically collected, and differed between the two sites. It 
became clear that an adequate evaluation of jail screening would require that standardized 
data collection procedures and tools be developed and implemented in all sites.  
In 2001 a standardized data collection instrument was developed for the project. 
The current jail screening staff were very involved with the design to ensure that it would 
meet their needs. To reduce redundant effort, the new form was designed to serve as both 
the data collection form and the lab slip to go with the blood sample to the lab for testing. 
The form also had to meet a Clinical Laboratory Improvement Amendments (CLIA) 
requirement that the name of the receiving laboratory be printed on the form. For ease of 
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use, the form was designed to scan into the computer using Optical Character 
Recognition (OCR) technology which allows the use of regular handwriting rather than 
filling in bubbles. A variable was added to the form to allow for the evaluation of 
screening activities in settings other than the jail.  
For a copy of the syphilis data instrument, please see Appendix C. Please note 
that although there are six different versions of the form (one for each county), only one 
is shown. 
 
HIV data collection form 
 
The two jails in Guilford county (Greensboro and High Point) offered HIV testing 
to inmates screened for syphilis under this SEE project. These tests were funded with 
CDC HIV counseling and testing (CTS) monies and processed at the State Lab in 
Raleigh. A standard form, used for all CTS testing in the state, was used to collect the 
information related to the HIV test. There was also a place on the syphilis form to 
indicate whether or not an HIV test was done and to record the form ID number for the 
HIV test. The HIV forms were sent with the samples to the State Lab. Syphilis screening 
form data were later matched to SLPH data to obtain the HIV test results. For a copy of 
the HIV data instrument, please see Appendix C. 
 
Data Collection Procedures  
 
The new form was put to use in all seven SEE jails in 2002. Prior to 
implementation, screening personnel were trained in the use of the new form. By 
September 2002, all 7 jails were both screening inmates for syphilis and collecting data. 
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Additional site visits were conducted after implementation to address any issues and 
ensure compliance with established procedures. 
In all jails, the screening process began with the screener providing syphilis 
information and education to the inmates followed by administration of the questionnaire 
and drawing blood for testing. When screening took place at booking, this was often an 
entirely ‘one on one’ process. In other situations, the education component was delivered 
to a group and then individuals were taken aside for the risk interview and blood draw. 
The trained screener asked all the questions of the inmate and filled out the form (forms 
were not to be filled out by the inmate). In some cases the person asking the questions 
was the same as the person drawing the blood sample, in others the screening was done 
with a team of two.  
The jail screener then tore off the back portion of the data collection form (which 
served as the lab slip) and sent the sample to the appropriate laboratory. If the sample was 
positive and no confirmatory test was on file for that patient, the sample was sent to the 
State Lab (SLPH) in Raleigh for confirmatory testing. In Robeson county, a STAT RPR 
(non-titered) test was performed locally and then all samples were forwarded to the State 
Lab for titered screening and confirmatory tests as needed.  
The rest of the form was either held by the screener or forwarded to a designated 
person who waited for the first titered results to come back and marked them on the form. 
The forms were then sent the HIV/STD Prevention & Care Branch.  
In the two jails also offering HIV testing, a separate HIV form was filled out in 
addition to the syphilis form and sent with the sample to the SLPH in Raleigh for testing. 
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The HIV form number was recorded on the syphilis form so that the data could later be 
matched to obtain the test results. 
 
Case Followup 
 
All positive samples detected through this project were reported to the appropriate 
health department and investigated according to standard procedures, described below. 
By North Carolina law, all positive syphilis and HIV tests must be reported to the 
local health departments and ultimately to the state. In some cases (as with HIV tests 
performed by private labs) the state is notified first and then the county. This notification 
is often done by phone and case investigation begins immediately. The HIV/STD 
Prevention and Care Branch has a system of eight Regional Offices that manage contact 
tracing and partner notification activities for syphilis and HIV. Positive test information 
is forwarded from the county or state to the appropriate office (based on the patient’s 
county of residence) for followup. These offices maintain databases of patients with 
positive syphilis tests for their region because titer history is needed to determine if a 
positive test represents a past case who is serofast, a past case who may be reinfected, or 
a possible new case of syphilis. Likewise, it is necessary to determine whether or not an 
incoming positive HIV test represents a previously reported infection.  
Patients who may represent new cases of syphilis or HIV will be contacted and 
interviewed by Disease Intervention Specialists (DIS). This interview has many purposes: 
behavioral counseling to prevent ongoing transmission, identification of partners who 
may have been exposed and who require testing themselves, diagnostic staging and 
assuring treatment of syphilis cases, and gathering of data regarding individual and 
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community risks associated with infection.  When these interviews are complete, the 
resulting data is gathered and entered into the patient management database for that 
region. New cases are formally reported to the State Health Department in Raleigh for 
inclusion in official statistics and reporting to CDC. 
Inmates positive for syphilis and/or HIV under this SEE project were reported to 
the state health department and case investigations were conducted as needed. This took 
place independently from the marking of syphilis test results on the SEE jail screening 
forms and their submission for data entry.  
 
2.2.4  Outcome Measures 
 
Jails forwarded syphilis screening forms to the State Health Department in 
Raleigh via FedEx about once a month. FedEx was used for security of the data, not to 
expedite delivery. Incoming syphilis screening forms should include patient 
demographics, the date of the blood draw, risk factors, screening location, and the 
preliminary titered result. Upon receipt, all forms were reviewed for completeness and 
attempts were made to locate missing information whenever possible.  
Completed forms were separated by syphilis test result. Negative screens were 
ready for data entry at any time. Forms for positive inmates were matched to surveillance 
data at both the regional and state levels determine final case status. After this thorough 
assessment, each positive was assigned a code as seen in Table 2.3. This complete case 
diagnosis approach is rarely used in syphilis screening studies and is a distinct strength of 
this study. 
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2.2.5  Data Management 
 
The SEE jail screening forms were scanned using optical character recognition 
(OCR) software to ‘read’ the letters, numbers, and checkmarks in the boxes. For this 
project, the system had been configured to require human verification of all fields. The 
software (Cardiff Teleform v7.0) provided its best ‘guess’ as to what the data field 
contains and the human verifier confirmed or corrected the information. For checkboxes, 
the software was nearly always correct in its assessment of whether or not there is or is 
not a mark in the box. Fields that contain letters or numbers required much closer 
attention. Numeric fields were best because there are only 10 possible responses. 
Alphanumeric fields were the most difficult due to the high number of possibilities 
(n=36) and problematic similarities between 0 and O, 1 and I, 8 and B, etc. Errors were 
highest when the data collector failed to write within the lines. Despite these issues, the 
scanning system worked very well. Most of the verification time was spent on the 
handful of fields with letters and numbers. Clicking through the checkboxes, which were 
almost always correct, was quite fast. It took less than one minute to “verify” a scanned 
form. This was much faster than manual data entry and approximates a double entry 
system. 
Verified form data was output to a Microsoft Access database which was later 
imported into SAS for data management and analysis. SAS programs were run to check 
the data for inconsistencies (males who are pregnant, illegal dates, etc.) and create 
composite variables.   
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Table 2.3: Outcome Measures for Syphilis Screening Data 
 
Code Outcome Notes 
000 False Positive Applied when titered result is positive but 
confirmatory test is negative 
710 Primary Syphilis Requires confirmation of specific physical 
symptoms on the patient. 
720 Secondary Syphilis Requires confirmation of specific physical 
symptoms on the patient. 
730 Early Latent Syphilis Applied to asymptomatic cases in which it can 
be confirmed that the infection was acquired 
less than one year ago. Requires confirmation 
of specific physical symptoms on the patient or 
a partner. 
740 Late Latent Syphilis of 
Unknown Duration 
Applied to asymptomatic cases in which meet 
very specific criteria: unable to document that 
infection was acquired less than one year ago, 
age 13-35, and titer ≥ 32 
745 Late Latent Syphilis  Applied to asymptomatic cases in which it can 
not be documented that the infection occurred 
less than one year ago and that do not meet the 
criteria above. 
765 Neurosyphilis Requires confirmation of specific physical 
symptoms on the patient. 
777 Past Syphilis Case Applied when the patient record confirms a 
past case of syphilis but the current titer does 
not indicate a new infection. These patients are 
not interviewed. Also called ‘record search 
closure’. 
888 Administrative Closure Some cases are closed without interview 
because they fall into a demographic not likely 
to be a new case (generally older persons with 
very low titers). This is done to prioritize field 
interview assignments. 
999 Lost to Follow Up Applied when DIS attempt but are unable to 
locate and interview a person with a positive 
screening test. 
  
 
HIV Data Entry 
 
SEE jail screening forms from Guilford County included a check box to indicate 
whether or not the patient had a test for HIV. This was the only HIV variable on the 
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syphilis screening form (see Appendix C). The rest of the information associated with the 
HIV test was completed on the HIV form (Appendix C) and sent to the SLPH along with 
the sample for analysis. This CDC form was first adopted for use when North Carolina 
offered anonymous HIV testing (prior to 1997) and identified patients using numbers 
preprinted on the form.  
When the jail screening staff in Guilford county screened an inmate for syphilis 
and HIV, they marked the box for “HIV test” on the syphilis form and indicated the form 
number associated with that test. These numbers were later matched against an HIV 
testing database from the SLPH to obtain HIV risk information and test results for those 
inmates.  
 
Multiple Observations for Individuals 
 
Some inmates appeared in the dataset multiple times because they were arrested 
more than once during the four-year study period. SEE jail screening staff were instructed 
to re-test individuals that had previously been screened if they had been out of jail and at 
risk for syphilis in the interim. These observations were legitimately ‘eligible’ to be in the 
numerator of new syphilis infections and it was therefore reasonable to retain them in the 
dataset. Their inclusion, however, could bias the demographic and risk profile towards 
recidivist inmates because their characteristics were ‘counted’ multiple times. 
Other inmates were re-tested multiple times in order to confirm that treatment of 
their syphilis case had been effective. The data collection instrument has a box to indicate 
when testing is being performed for this reason and these ‘test of cure’ observations were 
dropped from the dataset. 
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Missing Data 
 
Information was missing for some variables due to failure of the jail screener to 
ask for the information, failure of the jail screener to record the information, or inmate 
refusal to answer questions. Demographic data on each inmate was already been recorded 
by jail staff as part of the arrest record by the time the syphilis screener had access to the 
individual. At that point the individual had no reason to refuse disclosure of date of birth 
or other information since the jail already had this information. If demographic data was 
missing, it was assumed that it was missing at random. If an inmate had multiple 
observations in the dataset, demographic data from another observation was used to fill in 
missing data in another. 
Missing data for risk questions were addressed using sensitivity analyses, 
described in detail in section 2.6.6.  
 
Sample size considerations 
 
One goal of this dissertation project was to develop simple, yet effective, 
screening algorithms using the fewest possible variables. The limits that the study size 
placed on the number of possible variables in the models is described here. Table 2.4 
illustrates the number of inmates screened in the study and the number found to be cases. 
These numbers are used to calculate the maximum number of possible variables in the 
(meaningful) logistic regression model, using the formula below by Harrell18 where n is 
the total population screened, n1 represents cases, and n0 noncases. 
     
10*
**3 01
n
nn
esMaxVariabl =  
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Table 2.4: Inmates screened for syphilis and HIV in NC Jails 2002-2005 and 
calculations for maximum number of variables in logistic regression models 
 Male Female 
SYPHILIS   
Screened (n) 19,403 4,607 
New cases (n1) 98 57 
Noncases (n0 = n – n1) 19,305 4,550 
   
Max # variables in model 29 17 
   
HIV   
Screened (n) 2,985 641 
Prevalent cases (n1) 34 12 
Noncases (n0 = n – n1) 2,951 629 
   
Max # variables in model 10 4 
 
 
2.2.6  Study Design – Aim 1 
 
Aim 1 sought to: (a) examine the prevalence of syphilis and associated risk 
factors in male and female North Carolina jail inmates, (b) develop predictive models for 
syphilis infection based on demographics and self-reported risk factors, and (c) to use the 
models to develop and test a risk score to be used to improve the effectiveness of the jail 
screening program. 
 
Study population and outcome measures 
 
The data for these analyses included all male and female inmates screened for 
syphilis through the SEE jail screening project in 7 jails in 6 counties, 2002-2005. Data 
for repeat screening of individuals was used and appropriate statistical techniques were 
used to account for within-person variation. Separate models were developed for men and 
women using new syphilis cases as the outcome measure. 
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Data analysis and statistical methods 
 
Frequencies, distributions, and missing values of the demographic, risk behavior, 
and syphilis test result data were examined. Variables with excessive missing values were 
removed from the analysis. Unadjusted odds ratios and 95% confidence intervals were 
calculated to describe the associations between each covariate and new syphilis infection.  
Logistic regression for clustered data was used to account for lack of independence 
between multiple observations for individuals.  
Sensitivity analyses were performed to address two key questions. First, data were 
analyzed using generalized estimating equations and using logistic regression for 
clustered data. There were no meaningful differences in which variables would have been 
chosen for inclusion in full models 
 
Predictive models 
 
Candidate variables for the reference or “full” model included those with bivariate 
p≤0.25 and others identified from the literature, regardless of p-value. The predictors in 
the reference model were examined for collinearity using eigenvalues and tolerances. 
Final models for men and women were developed using manual backward elimination 
from the reference models. At each step, the variable with the highest p-values was 
removed until all variables remaining in the model had p≤0.05. Each successive model 
was assessed for performance using the Liklihood ratio test and goodness of fit using the 
Hosmer-Lemeshow test. The area under the receiver operating characteristic (ROC) 
curves for the reference and final models was also compared.  
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Risk score development and testing 
 
In order to preserve the multiplicative nature of the logistic models, risk scores 
were based on the beta coefficients from the models19-21. For purposes of comparison, we 
created three sets of risk scores. The first was a simple summation of the beta coefficients 
for each risk factor present. These fractional coefficients would not be practical to use in 
a screening algorithm so they were simplified. Unweighted scores were created by 
assigning a value of 1 to each factor present, 0 for each absent and summing across all 
variables. For weighted risk scores, beta coefficients were transformed by multiplying by 
two and rounding to the nearest whole integer.  
Cutoff points for sensitivity and specificity of the models were determined under 
the assumption that a limited number of tests could be performed in the screening 
program. We compared cutpoints for screening ≤30%, ≤50%, and ≤70% of the target 
population. Internal validity of the resulting models and risk score sensitivity and 
specificity was examined using bootstrap analysis in which the study population was 
resampled 1000 times with replacement18.  
 
Sensitivity Analyses  
 
Sensitivity analyses were performed to address two key questions. First, data were 
analyzed using both generalized estimating equations and using logistic regression for 
clustered data. There were no meaningful differences in ORs or 95% CI and the same set 
of variables would have been chosen for inclusion in full models. Logistic regression for 
clustered data was ultimately used because it allowed the use of likelihood ratio tests and 
GEE would not. 
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Second, the data collection instrument did not record yes and no responses to the 
risk behavior questions. Rather, the box was marked if the answer was yes and left blank 
if the answer was no. If all questions were asked and the inmate responded no to all of 
them, the screener was supposed to mark the box ‘none’ (please see screening form, 
Appendix C). With this design, there was no way to really know if (a) the screener asked 
some of the risk questions but not all of them or (b) the inmate refused to answer some of 
the risk questions but not all of them.  
To assess the impact of these coding issues, the data were analyzed two different 
ways. First, it was analyzed assuming that the form was used correctly. Each time a box 
was left blank, it was coded as “no”. This is the methodology reported in the results for 
this dissertation. A more conservative coding scheme was also created in which it was 
assumed that if any one of the risk questions or the “none” box was marked, then all the 
questions were asked and blanks were set to “no”. If none of the risk boxes nor the ‘none’ 
box was marked, it was assumed that none of the questions were asked and those 
responses were all set to “missing” rather than “no”. We found that there were no 
meaningful differences between these two schemes and that using the criteria of bivariate 
p<0.25, the same variables would have been included in the reference model under either 
one.  
 
2.2.7  Study Design – Aim 2 
 
Aim 2 sought to: (a) examine the prevalence of syphilis, HIV, syphilis-HIV 
coinfection, and associated risk factors in male and female inmates in two NC jails, (b) 
develop predictive models for infection with HIV and either syphilis or HIV, (c) to use 
the models to develop and test a risk score to be used to improve the effectiveness of the 
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jail screening program and (d) to conduct a cost assessment of the HIV program alone 
and the incremental cost of adding syphilis to an existing syphilis screening program. 
 
Study population and outcome measures 
 
The data for these analyses included male and female inmates screened for HIV 
and syphilis through the SEE jail screening project in 2 jails in 1 county, 2002-2005. 
Some inmates were screened multiple times during the study period. However, because 
the focus of this study was HIV, not syphilis, the study population was restricted to the 
first observation (i.e. first arrest) for each individual. Separate models were developed 
using two outcomes: (1) HIV infection and (2) HIV infection or new syphilis case 
(hereafter HIV/syphilis). Gender was included as a predictor in both models. 
 
Data analysis and statistical methods 
 
Frequencies, distributions, and missing values of the demographic, risk behavior, 
and HIV and syphilis test result data were examined. Variables with excessive missing 
values were removed from the analysis. Unadjusted odds ratios and 95% confidence 
intervals were calculated to describe the associations between each covariate and the two 
outcomes (HIV and HIV/syphilis).  
 
Models and risk scores 
 
Separate models for HIV and HIV/syphilis were developed using the same 
techniques described for Aim 1. The development of the risk scores was also similar. 
Predicted probabilities and unweighted scores were the same. Several possible methods 
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for creating the weighted scores were tested. It was determined that simply rounding the 
beta coefficients from the models to the nearest integer produced the optimal result.  
Testing of the risk scores was different for this study. All risk scores were set to 
cutpoints for hypothetically testing 50% of the jail population. Then the performance of 
the risk scores (sensitivity and specificity) was assessed for each of three outcomes: HIV 
only, Syphilis only, and HIV/syphilis. So, even though one of the models was designed to 
predict HIV infection, the ability of those same criteria to predict syphilis and 
HIV/syphilis was also examined. Again, internal validity was assessed using bootstrap 
analysis as described in Aim 1.  
Cost Assessment Analysis 
 
To address the issue of whether or not syphilis screening should be included in 
jail screening programs for HIV, program costs were examined. Four hypothetical cost 
scenarios based on screening strategy were prepared (standard testing for HIV only, 
standard testing for both syphilis and HIV, targeted testing for HIV only, and targeted  
testing for both syphilis and HIV).  Fixed costs included salaries for screening personnel 
and the cost of initial screening tests for all samples. Variable costs included quantitative 
and confirmatory testing performed on positive screening samples and were dependent 
upon the number of positive screening tests expected. Prevalence estimates for the 
standard scenarios were taken directly from the study population and those for the 
targeted scenarios were taken from the new populations that would be screened using the 
weighted risk scores from the HIV only model.  
Estimates of personnel costs and the number of inmates that could be screened per 
shift were obtained from the budgets for the North Carolina SEE jail screening project.  
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Estimated costs for laboratory tests were based on Medicaid reimbursement rates 
and were taken from an impact analysis performed by the North Carolina Division of 
Public Health in association with a change in HIV testing laws22. Costs per HIV case 
detected included the cost of HIV screening and confirmatory tests and all personnel 
costs because the HIV screening program was the funded entity. Since the addition of 
syphilis screening to the existing HIV program was in question, costs per case detected 
included only the cost of additional testing.  
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3.1  ABSTRACT 
 
Background 
 
As recommended by the Centers for Disease Control and Prevention, North 
Carolina instituted syphilis screening in county jails as part of its Syphilis Elimination 
program. Resource constraints limit the number of inmates that can be screened on any 
given shift in the jails. This paper aimed to develop and test algorithms to select inmates 
for screening at NC county jails.   
 
Methods 
 
This study included inmates screened for syphilis in seven North Carolina jails 
under Syphilis Elimination in 2002-2005. Study data were matched to surveillance 
records to obtain true syphilis case status. We created separate models for male and 
female inmates and used the β coefficients to develop weighted risk scores to predict new 
syphilis cases. The scores were applied to screening hypothetical proportions of the 
population and the sensitivity of the resulting cupoints in detecting syphilis was assessed. 
 
Results 
 
For men, the model yielded weighted risk scores with good sensitivity for the 
detection of new syphilis cases (82.7, 95% CI 75.0 – 90.3) when applied to testing 50% 
of the available inmates. The model included age, race/ethnicity and history of STD 
diagnosis. A sensitivity analysis found that background syphilis rate is not a good 
substitute for race/ethnicity and results in much weaker sensitivity (73.4%). For women, 
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no model could be developed because only one predictor, cocaine use, was associated 
with infection.  
 
Conclusions 
 
We recommend targeting syphilis screening for men based on the algorithm 
developed using race/ethnicity. Due to heightened concerns about congenital syphilis, 
screening all women is recommended.  
 
3.2  INTRODUCTION 
 
North Carolina is a state disproportionately affected by syphilis. When primary & 
secondary syphilis rates peaked in North Carolina in 1992, its rate was nearly three times 
higher than the national rate that year (36.2 vs. 13.3/100,000)1. Within the state, the vast 
majority of reported early syphilis cases are among non-Hispanic blacks (approximately 
70% per year, 2000-2004) though they make up only 22% of the State’s population2. 
Though much smaller in numbers, non-Hispanic Native Americans make up about 6% of 
reported early syphilis cases 2000-2004 but just over 1% of the state population2.  
In 1998, the Centers for Disease Control and Prevention (CDC) recognized that 
over 50% of reported primary and secondary syphilis cases in the United States came 
from just 28 counties.  In response, the CDC launched the Syphilis Elimination Effort 
(SEE) in 19993. North Carolina has six counties in the project, more than any other state. 
Since 1999, new case rates in North Carolina have declined dramatically, in part due to 
the success of SEE efforts to improve clinical services, surveillance, outbreak response, 
and community awareness2. However, an ongoing reservoir of transmission remains. Jail 
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screening may play a key role in accessing this difficult to reach group for case detection 
and treatment.  
Jails are locally operated and house persons arrested and awaiting trial and those 
sentenced to short terms of generally less than one year. In North Carolina, about 23% of 
the jail population at any given time are serving sentences; the remainder are pretrial 
detainees4. Because the average inmate stays in jail for less than two days5, screening in 
the jail setting functions as a form of community screening, often reaching individuals 
that do not otherwise have contact with the health care system.  
Personnel and other constraints limit the number of inmates that can be screened 
on any given shift in the jails. It is therefore desirable to focus efforts on those inmates at 
highest risk for testing positive. Any protocols used to determine which inmates to screen 
will require not only accuracy and effectiveness but also ease of use in the jail setting. 
The purpose of this analysis is to develop and test the performance of syphilis screening 
algorithms for use in North Carolina Jails. 
 
3.3  METHODS 
 
3.3.1  Study Population 
 
This study included men and women age 18 years and older screened for syphilis 
in seven North Carolina jails as part of Syphilis Elimination, 2002-2005.  No exclusion or 
inclusion criteria were used to determine who would be screened. However, due to the 
importance of screening women to prevent congenital syphilis, SEE staff were advised to 
screen as many female inmates as possible. Refusal rates were not formally tracked but 
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interviews with jail screening staff have indicated that most inmates who received 
education also accepted the offer of screening.  
 
3.3.2  Data Collection 
 
Screening procedures varied slightly depending on jail resources. In order to reach 
the largest number of inmates before they were able to post bond, screening typically 
took place at or near the intake area of the jail whenever possible. When intake screening 
was not feasible because of the physical layout of the jail or the availability of 
correctional staff, screening was conducted in the housing areas of the jail. In these 
situations, the program was generally screening inmates who had been in the facility 
longer than a day but shorter than two weeks.  
Health department or jail medical staff provided education on syphilis and other 
sexually transmitted diseases (STD) to inmates alone or in groups and then offered 
screening. Two of the seven jails also offered HIV testing. Inmates who agreed to 
screening were then taken aside for the administration of a risk questionnaire and to have 
their blood drawn for testing. Samples were then forwarded to the appropriate laboratory 
for processing and the data collection forms went to the NC Division of Public Health for 
analysis.    
As required by North Carolina law, all positive syphilis tests were reported to the 
local county health department. Reports were then forwarded to the NC Division of 
Public Health for investigation. For many patients, a past history of treated syphilis and 
titer readings indicated that the person did not have a new syphilis infection and the case 
was closed.  Individuals with positive tests who were possible new cases of syphilis were 
contacted and interviewed by Disease Intervention Specialists (DIS). New cases were 
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staged (primary, secondary, early latent, latent, latent of unknown duration, late with 
symptoms, neurosyphilis)and then reported to the State Health Department in Raleigh. 
Positive screening results for this study were matched to surveillance records to 
determine the outcome of these investigations and final case status.  
Inmates screened from 2002 to 2005 were included in this study. The study was 
approved by the University of North Carolina Public Health and Nursing Institutional 
Review Board (IRB). 
 
3.3.3  Measures 
 
The outcome for this study is the diagnosis of a new syphilis case of any stage 
(primary, secondary, early latent, latent, latent of unknown duration, late with symptoms, 
neurosyphilis). This complete case diagnosis approach is rarely used in syphilis screening 
research and was possible because the study data were linked to surveillance records that 
established case status and staging.  
The likelihood of acquiring an STD is related not only to individual risk behaviors 
but also to the likelihood of infection among the chosen pool of sex partners. To account 
for this concept, we included in our models a measure of background syphilis rate. We 
chose county rates to approximate communities; North Carolina has 100 counties which 
generally contain only one major city or town. Due to reporting delays, state surveillance 
data are typically not available until six months after the close of the year. To ensure that 
information would be available for implementation of the screening algorithm, we used 
the early syphilis (primary, secondary, and early latent) rate for two years prior for any 
given year. For example, the county X rate for 2000 would be applied to an inmate 
screened in county X in 2002. The SEE counties by definition have a history of high rates 
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of syphilis so the rates were classified as being in the top 10% or bottom 90% among all 
100 NC counties.    
Other possible predictor variables from the interview questionnaire include 
demographic information (gender, age, race/ethnicity, marital status, pregnancy status) 
and risk behaviors and conditions in the last six months (homelessness, victim of 
domestic violence, men having sex with men, multiple sexual partners, diagnosis of any 
STD, trading sex for drugs or money, use of: marijuana, alcohol, injection drugs, or 
cocaine). 
For bivariate and multivariate analyses, the race/ethnicity variable was collapsed 
to four categories based on prevalence of syphilis in the sample: black/African American 
non-Hispanic, Native American non-Hispanic, and Hispanic are compared to all other 
races (white, Asian/Pacific Islander, mixed race, and all others). 
 
3.3.4  Statistical Analyses 
 
Over the four year period of the study, 3,765 of the 18,506 inmates were re-
arrested and screened again. Therefore we present frequencies and distributions for all 
observations and for the first observation only to describe the dataset and population, 
respectively. We stratified all analyses by gender because (a) important predictors of new 
syphilis infection vary greatly by gender and (b) the benefits of screening also differ by 
gender which may necessitate divergent screening plans. 
Inmates repeatedly screened were at risk for syphilis each time they re-entered the 
community, leading us to use all observations in regression analyses. To develop syphilis 
prediction models, we used unconditional logistic regression for clustered data and 
obtained robust standard error estimates that adjust for within-subject correlation6, 7.  
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A "full" or reference model was developed using candidate variables from the 
literature, regardless of bivariate p-value, and covariates with bivariate p≤0.25. Candidate 
variables were assessed for collinearity by examining eigenvalues and tolerances. 
We used a manual backward elimination procedure to reduce the model until all 
variables remaining in the model had p≤0.05. The reference and final models were 
assessed for goodness of fit using the Hosmer-Lemeshow test. The area under the 
receiver operating characteristic (ROC) curve for the reference and final models were 
compared to ensure that variables removed did not greatly change model performance.  
The final models were used to create risk scores to be used in NC jails for 
screening. We created three sets of risk scores using the β coefficients from the models8-
10
. First, we summed the β coefficients for each risk factor that was present. This was 
done for comparison purposes only as it would not be practical to use this system in the 
field. Next we calculated unweighted risk scores by assigning 1 to each risk factor 
present and 0 if not present. Finally, we computed weighted scores by transforming the 
fractional β coefficients to integer values by multiplying by a constant and rounding. We 
calculated risk scores using several constants and chose to use the ones with the best 
sensitivity (2 for males, 1 for females).  
We applied the risk scores to hypothetically screening different proportions of the 
total available study population (≤70.0%,  ≤50.0%,  ≤30.0%) and obtained cutpoints for 
screening. Individuals with risk scores at or above the cutpoint would be chosen for 
screening, those below the cutpoint would not be screened. We then calculated the 
sensitivity and specificity of these different risk score cutpoints. We performed an 
examination of internal validity of risk score performance using bootstrap analyses in 
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which the cohort was resampled 1000 times with replacement11. We conducted statistical 
analyses using Stata SE version 8.0 (Stata Corporation, College Station, TX). 
 
3.4  RESULTS 
 
3.4.1  Study Population 
 
From 2002 to 2005, the North Carolina Syphilis Elimination Project performed 
24,171 syphilis screens on jail inmates age 18 years and older. We removed 125 
observations with missing screening results and another 36 with positive screening results 
but no documented outcome (new syphilis case, not a case, etc.). This study sample 
comprised 24,010 observations from 18,506 different people. 
Among the 18,506 individuals represented in the dataset, 14,746 (80%) had only 
one observation; 2,674 (14%) had two observations and 711 (4%) had three. The 
remaining 375 (2%) had 4-12 observations. No study participants experienced more than 
one syphilis event. 
Women represented 18% of the total individuals in the study population and 19% 
of the total observations. The average age at first observation was 32 years old for males 
and 33 for females. The screened inmates were primarily of black non-Hispanic 
race/ethnicity (59% of men and 51% of women)(Table 3.1). The study also included 
many Native Americans (11% of men and 14% of women screened) because one of the 
six SEE counties has a large Native American population.   
Women were far more likely to have a reactive syphilis screening test (8.1% vs. 
2.7% for men, OR 3.3, 95% CI 2.7 – 3.9) or to be diagnosed with a new, confirmed 
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syphilis case (1.2% vs. 0.5% for men, OR 2.5, 95% CI 1.8 – 3.4). Overall only about one 
in 5 reactive tests represented a new case.  
 
3.4.2  Results for Men 
 
Men who were black non-Hispanic (OR 3.5, 95% CI 1.5 – 8.2) or Hispanic (OR 
7.6, 95% CI 3.1 – 18.9) were more likely to be diagnosed with a new syphilis infection 
compared to whites and others (Table 3.2). Syphilis was also associated with age and 
STD diagnosis (OR 2.5, 95% CI 1.5 – 4.2). Marijuana use had an inverse relationship 
(OR 0.6, 95% CI 0.4 – 1.0). In addition, background syphilis rate, reporting multiple sex 
partners, alcohol use, and cocaine use were all associated enough for inclusion in the 
multivariate models (p≤0.25). 
The full or “reference” model included all variables significant in the bivariate 
analysis at p<0.25. After variable reduction, the final model included age, race/ethnicity, 
and history of STD diagnosis (Table 3.3). The ROC areas of the two models were similar 
(ROCref =0.761, ROCfinal =0.755, χ2 p=0.539) indicating that model performance was 
retained after variable reduction.  
To minimize potential concerns about using race/ethnicity as a screening 
criterion, we examined background syphilis rate as a possible surrogate in a sensitivity 
analysis. When background syphilis rate was substituted for race/ethnicity in the final 
model, the area under the ROC curve decreased substantially compared to the reference 
model (ROCref =0.761, ROCcomp =0.691, χ2 p=0.002) indicating that this substitution 
dramatically reduced the performance of the model. 
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The weighted risk scores ranged from zero for a white/non-Hispanic man, age 18-
24 years with no self-reported STD diagnoses in the past six months to a score of 11 for a 
Hispanic man, age 45 years or older, with previous STDs (Table 3.3). The use of this 
model to screen less than 50% of the inmate population had a screening “cutoff” of 4 and 
sensitivity of 82.7, specificity of 55.0 (Table 3.5). This scoring scheme would detect far 
more cases than either the unweighted score (sensitivity 15.3) or the weighted score for 
the comparison model with background syphilis rate substituted for race/ethnicity 
(sensitivity 73.4). The weighted score model performed consistently when validated 
using 1000 bootstrap samples.  
 
3.4.3  Results for Women 
 
In contrast to the analysis for males, new syphilis diagnosis was not strongly 
associated with race/ethnicity or age (Table 3.2). However, several risk behaviors were 
associated with the outcome: cocaine use (OR 3.1, 95% CI 1.8 – 5.3), trading sex for 
drugs or money (OR 2.3, 95% CI 1.6 – 4.5), reporting multiple sex partners (OR 2.4, 
95% CI 1.4 – 4.0), homelessness (OR 2.1, 95% CI 1.1 – 3.8), and STD diagnosis (OR 
2.0, 95% CI 1.2 – 3.5). Background syphilis rate was also associated with new syphilis 
diagnosis.  
As with men, we included all variables significant at p<0.25 in the bivariate 
analyses, and also included age based on a priori expectations (p<0.26). After model 
reduction, only one variable remained: reported cocaine use in the past six months (OR 
3.1, 95% CI 1.8 – 5.3) (Table 3.4). The area under the ROC curves for the two models 
was different and both were substantially smaller than the models for men (ROCref 
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=0.701, ROCfinal =0.636, χ2  p=0.119) indicating inferior model fit and that predictive 
value was lost in the model reduction.  
With only a single variable in the model, cocaine use, we were unable to produce 
meaningful risk scores. Screening less than 50% of the population based on this predictor 
alone yielded a very poor sensitivity of 64.9 (95% CI 52.1 - 77.7). 
 
3.5  DISCUSSION 
 
We developed useful risk scores with good sensitivity to predict syphilis infection 
in male jail inmates (Table 3.4). Using the weighted risk scores and a cutoff of  “4 or 
higher” for screening, we created a simple algorithm that could be used in the jail setting 
to select inmates for screening (Figure 3.1). The person conducting the screening would 
proceed through a series of three questions (age, race, and STD diagnosis in the past 6 
months) until the patient reaches a score of “4” and is selected for screening or reaches 
the end and is not recommended for screening. The results of this study provide a way to 
screen for syphilis more effectively. Targeted screening is especially important for male 
inmates because there are more of them in the jails (over 80% in 200612) and their rates 
of syphilis are lower than rates for female inmates (Table 3.1).  
The models were less useful in developing a model to select women for screening. 
Only one predictor, cocaine use, was strongly associated with syphilis and its sensitivity 
was poor. Given the higher prevalence of syphilis among female inmates and the 
potential risk of transmission of syphilis from mother to child, we recommend a policy of 
screening all women in SEE jails. 
The use of race/ethnicity as a criterion for screening for any disease, particularly a 
sexually transmitted disease, is likely to provoke controversy. Jail inmates are a 
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marginalized group. Screening for STDs in this setting may perpetuate negative 
stereotypes. Inclusion of race/ethnicity as a criterion may exacerbate this problem. For 
this reason, we evaluated the possibility of substituting another variable that was highly 
correlated with race/ethnicity and would have a high likelihood of association with the 
outcome. Background early syphilis rate represents the likelihood of exposure to a person 
with syphilis in a person’s home community. We used this parameter as a substitute for 
race/ethnicity to develop an alternative risk score. Unfortunately, the results of this 
evaluation were disappointing. Compared to the model with race/ethnicity, the weighted 
risk score based on background syphilis rate had substantially lower sensitivity (73.4% 
vs. 82.7%), which corresponds to missing over a quarter of the cases. Inclusion of 
race/ethnicity would yield nearly 10% more cases with the same number of tests.  
Despite the possible problems associated with race/ethnicity as screening criteria, 
we recommend the use of the screening algorithm we developed (Figure 3.1). Because 
resources will not allow the SEE to screen all male inmates, the risk score will facilitate 
targeting the screening program to those men who are most likely to have a new case of 
syphilis. It is possible that the impact of the sensitive issue may be mitigated somewhat 
by the realities of the administration of the algorithm. Age and race/ethnicity are 
routinely recorded in the course of the criminal booking process in the jails. The person 
performing the syphilis screening assessment would not need to ask these questions 
again. In practice, most inmates offered screening based on age or race/ethnicity 
information would not be aware of the criteria. Those who did not meet age or 
race/ethnicity criteria would be asked a single question: “Have you been diagnosed with a 
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sexually transmitted disease in the last 6 months?”  Those responding “yes” to this 
question may not be surprised or offended by an offer for syphilis screening.   
Personnel using the screening tool would, however, be familiar with the criteria 
and it is possible that the larger community may also become aware of it. It would be 
important to incorporate frank discussion of the issue into the training protocol for 
screening staff. They should be informed that the recommendations are being made after 
a great deal of research and consideration led to the conclusion that too many cases of 
syphilis would be missed if the race/ethnicity information were left out. The same would 
apply to the general public, should the issue arise. 
It is tempting to view the truthfulness of self-reported risk behaviors as a validity 
concern. In our study, high proportions of inmates were willing to disclose behaviors 
such as cocaine use (14.6% of men, 34.0% of women), and having multiple sexual 
partners (26.2% of men, 30.8% of women) (Table 3.1), indicating a certain level of trust 
in the screening staff. However, the aim of this study was not to explain or quantify risk 
behaviors in this population. Our goal was to develop screening algorithms. When 
applied in the field, these algorithms will rely on self-reported data therefore the use of 
such data to develop them is appropriate.   
The validity of our results does depend on the classification of the outcome and 
the representativeness of the study population. As previously described, there was no 
mechanism in place to document those who refused testing. This would be a problem if 
the models were meant to be explanatory. Since the implementation of the screening tool 
in the future would also be under a voluntary testing scenario, our study population 
should be a reasonable representation of this target population.  
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We were able to use surveillance records to follow up each of the positive test 
results in our study population. This true case approach is a distinct strength of this study 
because it provides a profile of newly diagnosed syphilis cases, the outcome of interest 
for jail screening programs. A diagnostic test alone does not supply adequate information 
to accurately diagnose and stage a syphilis case13-15. A large proportion of positive 
screening tests actually represent persons who have had syphilis in the past but are 
currently disease-free. To correctly diagnose current infection, test results should be 
compared to the patient’s titer history and if necessary, followed with a patient interview 
to determine if and when symptoms were present. Most research studies are unable to 
follow up positive screening results in this way and must rely on surrogates that do not 
actually measure new infections.  
The identification of previously undiagnosed syphilis cases through jail screening 
has benefits at several levels. Transmissibility of syphilis is especially high for the 
primary and secondary stages and drops off during the early latent stage16. Identifying 
and treating early syphilis cases is critical to halt ongoing transmission and control 
outbreaks. When late stage syphilis cases are identified, the primary benefit is to the 
patient who needs treatment to prevent serious sequelae of late stage syphilis. Because 
women can transmit syphilis to their infants in utero up to eight years past the initial date 
of their own infection, finding female syphilis cases at any stage is critical to the 
prevention of congenital syphilis cases17, 18.  
We believe that the models developed would perform well in the SEE screening 
counties from which the study population was drawn. These counties were the counties 
with the highest incidence and prevalence of new syphilis cases when they were chosen 
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for SEE in 1999. Generalization to other counties with much lower rates of syphilis may 
be more problematic. However, this screening approach may translate well to jail 
screening programs in other high prevalence counties in the Southern United States 
where inmate demographics may be similar. The selective screening guidelines 
developed here can improve the efficiency of jail screening programs for men and 
reinforce the importance of screening women. 
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Table 3.1: Characteristics of Inmates screened for syphilis in NC Jails 2002-2005 
 
 MALES FEMALES 
 All Observations Individuals 
(1st obs only) 
All Observations Individuals 
(1st obs only) 
Characteristic n % n % n % n % 
         
SYPHILIS         
Screened 19403 100.0 15098 100.0 4607 100.0 3408 100.0 
Reactive Syphilis 
Test 
515 2.7 382 2.5 375 8.1 250 7.3 
New Syphilis Case 
(any stage) 
98 0.5 85 0.6 57 1.2 42 1.2 
         
Age         
  18-24 5306 27.4 4262 28.2 844 18.3 663 19.5 
  25-34 6499 33.5 5078 33.6 1776 38.6 1263 37.1 
  35-44 5226 26.9 3904 25.8 1577 34.2 1148 33.7 
  45+ 2372 12.2 1854 12.3 410 8.9 334 9.8 
         
Race/Ethnicity         
  White 3585 18.5 2925 19.4 1386 30.1 1052 30.9 
  Black NH 11453 59.0 8837 58.5 2261 49.1 1726 50.7 
  Native Am NH 2468 12.7 1598 10.6 771 16.7 467 13.7 
  Hispanic  1654 8.5 1507 9.9 139 3.0 117 3.4 
  Asian/PI 57 0.3 57 0.3 11 0.2 8 0.2 
  Other/Unknown 88 0.5 84 0.6 22 0.5 21 0.6 
  Missing 98 0.5 98 0.7 17 0.4 17 0.5 
         
Any Pregnancy 
Last 12 mo (incl 
current) 
        
  Yes -- -- -- -- 324 7.0 241 7.1 
  No -- -- -- -- 2595 56.3 1882 55.2 
  Missing -- -- -- -- 1688 36.6 1285 37.7 
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 MALES FEMALES 
 All Observations Individuals 
(1st obs only) 
All Observations Individuals 
(1st obs only) 
Characteristic n % n % n % n % 
         
 
 
        
PSEL Rate in top 
10% NC Counties 
9189 47.4 6482 42.9 2306 50.1 1546 45.4 
         
RISKS         
Homeless 1220 6.3 952 6.3 634 13.8 456 13.4 
Domestic Violence 
Victim  
-- -- -- -- 861 18.7 644 18.9 
Men Sex w. Men 119 0.6 100 0.7 -- -- -- -- 
Multiple Sex 
Partner 
5024 25.9 3960 26.2 1488 32.3 1048 30.8 
STD Diagnosis 1721 8.9 1341 8.9 863 18.7 604 17.7 
Trade Sex for 
Drugs or Money 
927 4.8 724 4.8 943 20.5 620 18.2 
Alcohol Use 10637 54.8 8325 55.1 2114 45.9 1560 45.8 
Marijuana Use 6461 33.3 4854 32.2 1716 25.5 798 23.4 
Injection Drug Use 223 1.2 183 1.2 156 3.4 111 3.3 
Cocaine Use 3127 16.1 2210 14.6 1756 38.1 1160 34.0 
         
NH = non-Hispanic, PSEL = Primary, secondary and early latent syphilis 
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Table 3.2: Bivariate Associations of Demographics and Risk Factors with New Syphilis Case Diagnosis among Inmates 
screened for syphilis in North Carolina Jails, 2002-2005 
 
 MALES FEMALES 
Characteristic Cases OR CI p Cases OR CI p 
Age         
  18-24 10 Ref Ref <0.01 5 Ref Ref 0.26 
  25-34 22 1.8 0.85 – 3.8 -- 27 2.6 1.0 – 6.7 -- 
  35-44 39 3.9 2.0 – 8.0 -- 19 2.1 0.7 – 5.5 -- 
  45+ 27 6.1 2.3 – 12.0 -- 6 2.5 0.7 – 8.2 -- 
         
Race/Ethnicity         
  White/Other 6 Ref Ref <0.01 13 Ref Ref 0.42 
  Black NH 65 3.5 1.3 – 8.2 -- 34 1.7 0.87 – 3.1 -- 
  Native Am NH 7 1.8 0.59 – 5.3 -- 9 1.3 0.55 – 3.0 -- 
  Hispanic  20 7.6 3.1 – 18.9 -- 1 0.8 0.10 – 5.9 -- 
         
Any Pregnancy Last 12 mo 
(incl current) 
-- -- -- -- 2 0.5 0.12 – 2.2 0.36 
         
PSEL Rate in top 10% NC 
Counties 
54 1.4 0.91 – 2.0 0.13 34 1.5 0.87 – 2.5 0.15 
         
RISKS         
Homeless 8 1.3 0.64 – 2.7 0.45 14 2.1 1.1 – 3.8 0.02 
Domestic Violence Vict -- -- -- -- 10 0.9 0.47 – 1.8 0.82 
Men Sex w. Men 1 1.7 0.23 – 12.1 0.61 -- -- -- -- 
Multiple Sex Partners 19 0.7 0.42 – 1.1 0.14 30 2.4 1.4 – 4.0 <0.01 
STD Diagnosis 19 2.5 1.5 – 4.2 <0.01 18 2.0 1.2 – 3.5 0.01 
Trade Sex for Drugs or Money 4 0.9 0.31 – 2.3 0.75 23 2.7 1.6 – 4.5 <0.01 
Alcohol Use 48 0.8 0.53 – 1.2 0.25 26 1.0 0.6 – 1.7 0.97 
Marijuana Use 23 0.6 0.38 – 1.0 0.04 14 1.0 0.51 – 1.7 0.87 
Injection Drug Use 1 0.9 0.12 – 6.4 0.91 3 1.6 0.49 – 5.2 0.44 
Cocaine Use 20 1.3 0.82 – 2.2 0.24 37 3.1 1.8 – 5.3 <0.01 
NH = non-Hispanic, PSEL = Primary, secondary and early latent syphilis 
  
84 
Table 3.3: Males -- Adjusted Odds Ratios and Risk Scores for New Syphilis Diagnosis among Inmates screened for syphilis in 
North Carolina Jails, 2002-2005 
 Reference Model 
 
Obs = 19,305 
ROC Area = 0.7614 
Final Model 
With Race/Ethnicity Information 
Obs = 19,305 
ROC Area = 0.7555 
Comparison Model 
With Background Syphilis Rate 
Obs = 19,305 
ROC Area = 0.6909 
Characteristic OR (95% CI) β OR (95% CI) β W U OR (95% CI) β W U 
           
AGE           
  18-24 ref ref ref ref 0 0 ref ref 0 0 
  25-34 1.7  (0.81 – 3.7) 0.54 1.8  (0.84 – 3.8) 0.58 1 1 1.8  (0.84 – 3.8) 0.58 1 1 
  35-44 4.3  (2.1 – 8.1) 1.46 4.6  (2.3 – 9.3) 1.53 3 1 3.9  (2.0 – 7.9) 1.37 3 1 
  45+ 6.7  (3.2 – 14.0) 1.89 7.3  (3.5 – 15.0) 1.98 4 1 6.0  (2.9 – 12.4) 1.78 4 1 
           
RACE/ETHNICITY           
  White/Other ref ref ref ref 0 0 -- -- -- -- 
  Black NH 3.2  (1.4 – 7.5) 1.16 3.1  (1.3 – 7.3) 1.14 2 1 -- -- -- -- 
  Native Am. NH 1.9  (0.64 – 5.5) 0.63 1.9  (0.64 – 5.6) 0.64 1 1 -- -- -- -- 
  Hispanic 11.1 (4.3 – 28.4) 2.41 10.8 (4.3 – 27.1) 2.38 5 1 -- -- -- -- 
           
PSEL Rate top 10% -- -- -- -- -- -- 1.5  (0.97 – 2.3) 0.39 1 1 
           
RISKS           
Multiple Sex 
Partners 
0.73  (0.41 – 1.3) -0.32 -- -- -- -- -- -- -- -- 
STD Diagnosis 2.6  (1.5 – 4.4) 0.94 2.4  (1.4 – 4.1) 0.87 2 1 2.6  (1.5 – 4.6) 0.97 2 1 
Alcohol Use 0.77  (0.49 – 1.2) -0.26 -- -- -- -- -- -- -- -- 
Marijuana Use 1.1  (0.65 – 1.8) 0.09 -- -- -- -- -- -- -- -- 
Cocaine Use 1.3  (0.77 – 2.3) 0.29 -- -- -- -- -- -- -- -- 
           
Constant -- -7.44 -- -7.60 -- -- -- -6.59 -- -- 
ROC =  Receiver Operator Characteristic curve, NH = non-Hispanic, OR = odds ratio, CI = 95% confidence interval, β = model beta, W = weighted risk score, U 
= unweighted risk score 
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Table 3.4: Females -- Adjusted Odds Ratios and Risk Scores for New Syphilis Diagnosis among Inmates screened for syphilis 
in North Carolina Jails, 2002-2005 
 
Reference Model 
Obs = 4,607 
ROC Area = 0.7005 
Final Model 
Obs = 4,607 
ROC Area = 0.6357 
Characteristic OR CI β OR CI β W U 
         
AGE         
  18-24 ref ref ref ref ref ref -- -- 
  25-34 2.1 0.81 – 5.6 0.76 -- -- -- -- -- 
  35-44 1.7 0.63 – 4.6 0.54 -- -- -- -- -- 
  45+ 2.3 0.70 – 7.7 0.84 -- -- -- -- -- 
         
County PSEL Rate in Top 
10%  
1.7 0.95 – 2.9 0.50 -- -- -- -- -- 
         
RISKS         
Homeless 1.2 0.62 – 2.3 0.18 -- -- -- -- -- 
Multiple Sex Partners 1.3 0.62 – 2.9 0.29 -- -- -- -- -- 
STD Diagnosis 1.4 0.74 – 2.5 0.30 -- -- -- -- -- 
Trade Sex for Drugs or 
Money 
1.3 0.55 – 3.2 0.28 -- -- -- -- -- 
Cocaine Use 2.0 0.98 – 4.2 0.71 3.1 1.8 – 5.3 1.11 1 1 
         
Constant -- -- -5.92 -- -- -4.95 -- -- 
ROC =  Receiver Operator Characteristic curve, OR = odds ratio, CI = 95% confidence interval, β = model beta, W = weighted risk score, U = unweighted risk 
score 
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Table 3.5: Performance of Selective Screening Criteria among Inmates screened for syphilis in North Carolina Jails, 2002-
2005 
Scoring 
Method 
MALES 
Final Model 
With Race Information 
(n=19,305) 
MALES 
Comparison Model 
With Background Syphilis Rate 
(n=19,305) 
FEMALES 
Final Model 
(n=4,607) 
% Tested Cutoff Sensitivity 
95% CI 
Specificity 
95% CI 
Cutoff Sensitivity 
95% CI 
Specificity 
95% CI 
Cutoff Sensitivity 
95% CI 
Specificity 
95% CI 
Predicted 
Probability 
         
  ≤70 0.002 91.8 
86.3-97.4 
33.3 
32.7-34.0 
0.004 81.6 
73.8-89.4 
40.3 
39.7-41.0 
-- -- -- 
  ≤50 0.003 82.6 
75.0-90.3 
55.0 
54.3-55.7 
0.004 73.4 
64.6-82.4 
55.9 
55.2-56.6 
0.021 64.9 
52.1-77.7 
62.2 
60.8-63.6 
  ≤30 0.008 49.0 
38.9-59.1 
84.0 
83.5-84.6 
0.006 56.1 
46.1-66.1 
70.3 
69.7-71.0 
0.021 64.9 
52.1-77.7 
62.2 
60.8-63.6 
Weighted 
Risk Score 
         
  ≤70 3 91.8 
86.3-97.4 
33.4 
32.7-34.0 
2 81.6 
73.8-89.4 
40.3 
39.7-41.0 
-- -- -- 
  ≤50 4 82.7 
75.0-90.3 
55.0 
54.3-55.7 
3 71.4 
62.3-80.5 
57.5 
56.8-58.2 
-- -- -- 
  ≤30 6 49.0 
38.9-59.1 
84.0 
83.5-84.6 
4 53.1 
43.0-63.1 
72.5 
71.9-73.2 
-- -- -- 
Unweighted 
Risk Score 
         
  ≤70 2 87.8 
81.1-94.4 
39.0 
38.3-39.7 
2 57.1 
47.2-67.1 
59.6 
58.9-60.3 
-- -- -- 
  ≤50 3 15.3 
8.1-22.6 
94.1 
93.8-94.4 
2 57.1 
47.2-67.1 
59.6 
58.9-60.3 
-- -- -- 
  ≤30 3 15.3 
8.1-22.6 
94.1 
93.8-94.4 
3 9.2 
3.4-15.0 
98.2 
98.1-98.4 
-- -- -- 
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Figure 3.1: Syphilis Screening Algorithm – Males 
 
AGE  RACE  STD DIAGNOSIS LAST 6 
MONTHS 
 SCREEN 
       
18-24   (0)  Hispanic   (5)    Screen 
       
  Black NH   (2)  Yes   (2)  Screen 
    No   (0) 
STOP – DO NOT SCREEN 
  
  Native American NH   (1) 
 
    
  White/Asian/Other Race   (0) 
STOP – DO NOT SCREEN 
    
       
25-34   (1)  Hispanic   (5)    Screen 
       
  Black NH   (2)  Yes   (2)  Screen 
  
Native American NH   (1) 
 No   (0) 
STOP – DO NOT SCREEN 
  
       
  White/Asian/Other Race   (0) 
STOP – DO NOT SCREEN 
    
       
35-44   (3)  Hispanic   (5)     
       
  Black NH   (2)    Screen 
       
  Native American NH   (1)     
       
  White/Asian/Other Race   (0)  Yes   (2)  Screen 
    No   (0) 
STOP – DO NOT SCREEN 
  
       
45+   (4)      Screen 
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4.1  ABSTRACT:  
 
Background 
 
The Centers for Disease Control and Prevention has recently shifted focus from 
syphilis to expanded HIV screening in county jails. We address (a) whether or not jail 
HIV screening should be targeted and (b) whether or not syphilis screening should be 
added to the HIV screening programs.  
 
Methods 
 
This study includes inmates screened for both syphilis and HIV in two North 
Carolina jails under Syphilis Elimination in 2002-2005. We created models to predict two 
different outcomes: HIV only and HIV or syphilis. We created risk scores from the 
models and assessed sensitivity and specificity of the models to detect HIV only, syphilis 
only, and either infection. We applied the prevalence estimates from the original study 
data and from the most optimal models to program cost models in order to assess the 
additional costs of targeted screening and of adding syphilis to the protocol.  
 
Results 
 
The weighted risk scores from the HIV only model had the best sensitivity for the 
detection of HIV (82.6, 95% CI 71.2 – 94.0). If inmates are selected for screening based 
on this model, the sensitivity for detection of new syphilis cases is also good (73.3, 95% 
CI 56.5 – 90.1). Under this scenario, the overall cost of the screening program increases 
slightly with targeted vs. not targeted screening (<5.0%). However, the cost per HIV case 
detected declines dramatically (from $2,189 to $1,262).  
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Conclusions 
 
We recommend targeting HIV jail screening based on HIV data. In communities 
with incident syphilis infections, we recommend adding syphilis screening to the HIV 
protocol. 
 
4.2  INTRODUCTION 
 
Incarcerated populations have high rates of both human immunodeficiency virus 
(HIV) and syphilis. The HIV prevalence has been found to range from 3.8-25.8% for 
women1-5 and 1.8-16.1% for men1-3, 6-8. In correctional settings, the highest rates are 
among women1-3, older age groups3-6, 8, and those of Black3-6, 8, 9 or Hispanic1, 4, 6, 8 race-
ethnicity. 
Syphilis rates are also high in correctional settings, from 1.4-22.2% for women1, 4, 
5, 10-19
 and 0.6%-5.7% for men1, 6, 7, 12, 15, 17-20.  Female inmates consistently have higher 
prevalence of syphilis than their male counterparts1, 12, 15, 17-19. Syphilis is also more likely 
to be detected in inmates in older age groups (≥ age 30)5, 17-20 and among those of Black5, 
12, 18-21
 or Hispanic19, 20 race-ethnicity. 
HIV and syphilis screening programs have been implemented in correctional 
settings throughout the United States to detect cases and link patients to treatment and 
care. Jail screening in particular has the capacity for broad impact. Most jail inmates are 
released in less than two days22. Consequently, screening in the jail setting functions as a 
form of community screening, often reaching individuals who might not otherwise get an 
HIV or syphilis test. For each case diagnosed, additional cases may be detected through 
partner notification and contact tracing.  
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Jail administrators are charged with housing inmates who are awaiting trial or 
have received a short sentence (generally less than one year). Their primary mission is to 
maintain the safety of the inmates and the jail employees. Public health programs like 
STD screening must operate subordinate to that mission. Screening personnel must be 
escorted by guards to maintain their safety and to ensure that testing supplies such as 
needles do not end up in the hands of inmates. Even with unlimited health department 
staff, the availability of guard support would limit the amount of screening that can 
actually be accomplished.  Therefore, screening programs must be designed to screen the 
right inmates with limited time available.  
The Centers for Disease Control and Prevention (CDC) specifically recommended 
screening for syphilis in jails in the 1999 publication “National Plan to Eliminate Syphilis 
from the United States”23. More recently, CDC funding for the Syphilis Elimination 
Effort (SEE) has decreased dramatically24. At the same time, the agency has provided 
new funding for the expansion of HIV testing programs, including a large jail screening 
inititative25. An important question is whether continued syphilis screening will fit into 
this new paradigm. In this analysis, we use data from the Syphilis Elimination jail 
screening program in North Carolina (2002-2005) to develop screening algorithms for 
HIV screening with and without the addition of syphilis screening.  
 
4.3  METHODS 
 
4.3.1  Study Population 
  
As part of the enhanced surveillance objective of Syphilis Elimination, the North 
Carolina Division of Public Health (DPH) conducted syphilis screening in seven county 
jails in six counties. This study used data collected in the two jails (in one county) that 
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opted to add HIV testing to their syphilis screening programs. Male and female inmates 
age 18 and older, screened for both syphilis and HIV from January 1, 2002 to June 30, 
2005 were included in the analysis. 
 
4.3.2  Data Collection 
 
Staff from the local health department, jail medical unit, and a local community-
based organization (CBO) provided education on syphilis and HIV to inmates alone or in 
groups and then offered screening. Inmates who agreed to screening were then taken 
aside for the administration of a risk questionnaire and to have their blood drawn for 
testing. Staff were encouraged to screen as many women as possible as a means to 
prevent perinatal HIV transmission and congenital syphilis.  
Samples for HIV testing were forwarded to the State Laboratory of Public Health 
(SLPH) in Raleigh and underwent antibody testing using standard HIV type 1 (HIV-1) 
enzyme immunoassay (EIA) and Western blot (WB) analysis. Samples negative or 
indeterminate on EIA were placed in pools of 90 specimens (containing 9 pools of 10) 
and screened by nucleic acid amplification (NAAT) for HIV-1 RNA as described 
previously26. Samples for syphilis testing were forwarded to the lab at the Guilford 
County Department of Public Health for screening using Rapid Plasma Reagin (RPR) 
tests. Positive samples were then forwarded to the SLPH for confirmatory testing using 
Treponema pallidum particle agglutination test (TP-PA) or MHATP 
microhemagglutination-Treponema pallidum test (MHATP). Questionnaires were sent to 
the NC Division of Public Health for entry and were later linked to test results.    
Refusal rates were not formally tracked, but interviews with jail screening staff 
have indicated that most inmates who received education also accepted the offer of 
  95 
testing. About 98% of male and female inmates who accepted syphilis testing also agreed 
to be tested for HIV. The study was approved by the University of North Carolina Public 
Health and Nursing Institutional Review Board (IRB). 
 
4.3.3  Measures 
 
We conducted two sets of analyses. In the first, we used HIV infection alone as 
the outcome to reflect the current environment with respect to CDC funding. Samples 
testing positive for HIV-1 antigen (Western Blot) or HIV-1 RNA (NAAT) were 
considered to be positive26. In the second set of analyses, we used a composite variable of 
HIV infection or new syphilis case (hereafter HIV/syphilis) to reflect the possibility of 
adding syphilis screening to HIV screening regimens. The syphilis outcome incorporated 
initial screening with rapid plasma reagin (RPR), linked to NC syphilis surveillance data 
to establish the current case status and stage of infection (primary, secondary, early latent, 
latent, latent of unknown duration, late with symptoms, neurosyphilis).   
Potential predictor variables were taken from the interview questionnaire and 
included demographic information (gender, age, race/ethnicity) and risk behaviors and 
conditions in the last six months (homelessness, men having sex with other men, multiple 
sexual partners, diagnosis of any STD, trading sex for drugs or money, use of: marijuana, 
alcohol, injection drugs, or cocaine). Participants were also asked to report whether they 
had ever been tested for HIV. 
For bivariate and multivariable analyses, the race/ethnicity variable was collapsed 
into two categories to address the issue of small cell sizes and with the aim of creating a 
high risk and a low risk group. The high risk category included black/African American 
non-Hispanic and Hispanic of any race and the low risk group included all other race 
  96 
ethnicity combinations: white non-Hispanic, Native American non-Hispanic, 
Asian/Pacific Islander non-Hispanic, mixed race, and all others. Both HIV and syphilis 
literature support the inclusion of black non-Hispanic and Hispanic in the high risk 
group1, 3-6, 8, 9, 12, 18-21. 
To describe gender and male sexual risk groups, we created a composite variable 
with three categories: men who reported having sex with men (MSM), men who did not 
report MSM (i.e. heterosexual men), and women. The referent category was set to “men 
who did not report MSM” because this group had the lowest risk for both HIV and 
syphilis.  
 
4.3.4  Statistical Analyses 
 
We restricted our analysis to the first observation for each individual among 
persons tested for both HIV and syphilis and for whom valid test results were available. 
Some inmates were arrested and screened multiple times throughout the four-year study 
period. Syphilis is fully curable and successfully treated cases are at risk for re-acquiring 
syphilis each time they re-enter the community. This is not true, however, for HIV which 
is the primary focus of this study. For each of the two outcomes (HIV infection vs. HIV 
infection or new syphilis diagnosis), we examined frequencies, distributions and 
unadjusted bivariate odds ratios for each covariate.   
We used multivariable logistic regression to develop predictive models for each 
outcome. A "full" or reference model was developed using covariates with bivariate 
p≤0.25. Candidate variables were assessed for collinearity using eigenvalues and 
tolerances. We also created and tested interaction terms for the composite sexual 
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behavior variable (males reporting MSM, males not reporting MSM, women) and each 
covariate. If a model with the covariate and its interaction term was significantly different 
from the model with just the covariate using a likelihood ratio test at p<0.05, the 
interaction term was retained in the reference model. 
We used a manual backward elimination procedure to create the final model. We 
examined likelihood ratio tests and the area under the receiver operating characteristic 
(ROC) curve for each model to ensure that the removal of each successive variable did 
not significantly reduce model performance. Backward elimination of variables continued 
until all variables remaining in the model had p values ≤0.05. All models were assessed 
for goodness of fit using the Hosmer-Lemeshow test.  
The final models were used to create risk scores to serve as the basis for jail 
screening algorithms for HIV and syphilis testing27-29. The first set of scores directly used 
the β coefficients from the models. These “predicted probability” scores were closest to 
the final model but too complex to use in the field and were done for comparison only. 
The greatest degree of simplicity was achieved with the “unweighted” scores which 
assigned a value of 1 to each attribute and 0 to each referent. We also developed a 
“weighted” risk score after testing three methods of weighting to maintain some 
complexity and prediction based on the β, but providing some relative simplification 
from the full linear combination of the β coefficients. The three weighting methods 
included rounding the β coefficients to the nearest integer, dividing them by the smallest 
β coefficient and rounding, and multiplying by two and rounding. We examined the area 
under the ROC curves and the sensitivity and specificity of models using the scores in 
place of the original variables to guide our choice of which method to use. For both the 
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HIV outcome model and the HIV/syphilis model, rounding the β coefficients to the 
nearest integer produced the optimal result.  
We then applied these risk scores to hypothetically test 50% of the total available 
screening population.  For each of the two models we calculated the sensitivity and 
specificity of the risk scores in predicting each of three outcomes: HIV only, syphilis 
only, HIV or syphilis. Model coefficients, risk scores, sensitivity and specificity were all 
validated using bootstrap analyses in which the cohort was sampled 1000 times with 
replacement30. All statistical analyses were conducted using Stata SE version 8.0 (Stata 
Corporation, College Station, TX).  
 
4.3.5  Costs Analysis 
 
Using the North Carolina Syphilis Elimination jail screening program as a model 
for the new programs emphasizing HIV testing, the primary costs of jail screening are 
described. We present results for four hypothetical scenarios based on screening strategy 
(standard sample testing for HIV only, standard sample testing for both syphilis and HIV, 
targeted sample testing for HIV only, and targeted sample testing for both syphilis and 
HIV). Fixed costs include salaries for screening personnel and the cost of initial screening 
tests for all samples. Variable costs include quantitative and confirmatory testing 
performed on positive screening samples and are dependent upon the number of positive 
screening tests expected.  
Disease prevalence estimates for the standard sample scenarios were taken 
directly from the screened study population because that was the method under which the 
data were collected. The standard screening method approximates a universal screening 
approach since testing is offered to all inmates equally. For targeted testing, estimates 
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were taken from the populations that would be screened using risk scores developed in 
this study. We assumed the number of samples requiring additional HIV testing to be 
equal to the estimated prevalence. We chose not to make any adjustments for false 
positives because the rate is known to be very low31. Estimates of personnel costs and the 
number of inmates that could be screened per shift were obtained from the North 
Carolina SEE jail screening project budgets. Estimated costs for laboratory tests were 
based on Medicaid reimbursement rates and were taken from an impact analysis 
performed by the North Carolina Division of Public Health in association with a change 
in HIV testing laws32. Costs per HIV case detected included the cost of HIV screening 
and confirmatory tests and all personnel costs because the HIV screening program is the 
funded entity. Since the addition of syphilis screening to the existing HIV program is in 
question, costs per case detected include only the cost of additional testing.  
 
4.4  RESULTS 
 
4.4.1  Study Population 
 
During the study period, 5,441 samples were taken from inmates 18 years of age 
and older who were screened for syphilis in the two participating jails. Many individuals 
were re-arrested and screened more than once. We removed 128 observations for which 
no HIV test was performed, 419 with missing syphilis or HIV test results, and 30 not 
considered at risk (second HIV test, syphilis test of cure). Finally, we restricted the 
remaining sample of 4,864 to the first observation for each individual leaving 3,626 
records for analysis.  
Women represented 17.7% of the total inmates in the study (Table 4.1). The 
average age for both men and women was 33years. Screened inmates were primarily 
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black non-Hispanic (63.9%) and white non-Hispanic (27.9%). Hispanics made up 5.5% 
of the study population, more than all remaining race/ethnicity groups combined.  For all 
of the risk categories that applied to both men and women, women were more likely to 
report than men.  
Forty-six people (1.3% of the study population) were found to be HIV positive. 
Four of these individuals also had reactive syphilis tests yet none were found to have 
current syphilis disease upon followup. Most of the HIV cases were among men (n=34) 
but they had a lower positivity rate (1.1%) than women (n=12 cases, 1.9%). Similarly, 
there were 99 men with a reactive syphilis test. Of these, 22 were confirmed new cases of 
disease (0.74%). Among women there were 59 reactive tests and eight new syphilis cases 
(1.3%) (Table 4.1).  
 
4.4.2  Results for HIV infection 
 
Women (OR 1.8, 95% CI 0.92 - 3.5 ) and men who reported sex with other men 
(OR 28.5, 95% CI 7.5 - 108.5) were more likely than heterosexual men to have HIV 
infection (Table 4.2). The outcome was also associated with increasing age and with 
Hispanic/Black non-Hispanic race ethnicity (OR 3.9, 95% CI 1.5 - 9.9 ). None of the risk 
categories was predictive of disease with the curious exception of marijuana use which 
had an inverse effect (OR 0.33, 95% CI 0.08 - 1.4). 
The full or “reference” model contained the composite sex variable, age, 
race/ethnicity, ever tested for HIV, and marijuana use (Table 4.3).  After backward 
elimination, the final model included sex, age, race/ethnicity and ever tested for HIV. The 
ROC curves for the full and final models were similar (ROCref =0.7499, ROCfinal 
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=0.7360, χ2 p=0.34) and model fit was good (Hosmer-Lemeshow goodness of fit test 
p=0.85).  
We created risk scores using the beta coefficients from the models directly 
(predicted probabilities) and indirectly (weighted and unweighted risk scores) (Table 
4.3). These scores were applied to hypothetically screening 50% of the available 
population to create cutoffs (at or above the cutoff = screened, below the cutoff = not 
screened). The sensitivity and specificity of each cutoff to detect each of three outcomes 
(HIV, syphilis, either) was assessed (Table 4.5). The weighted risk scores had the same 
sensitivity and specificity as the model predicted probabilities. In other words, there was 
no loss in performance when scores were simplified by rounding the beta coefficients to 
the nearest integer. Performance of the unweighted risk scores was always inferior, 
sometimes markedly so. We will focus the rest of our discussion on the weighted risk 
scores. 
For the HIV outcome model, the lowest scoring individual type would be a 
heterosexual man, age 18-24, never tested for HIV, with a race/ethnicity in the referent 
group (total score=0)(Table 4.3). The highest scoring individual would be MSM, age 25 
or older, previously tested for HIV, and of Hispanic or Black non-Hispanic race/ethnicity 
(total score=6). A risk score cutoff of 3 or above will lead to screening less than 50% of 
the available inmate population. This scenario has good sensitivity for the detection of 
HIV (82.6%, 95% CI 71.2 - 94.0) which is not surprising since the model was built to do 
exactly that. Its ability to detect syphilis is inferior to HIV but still quite reasonable 
(sensitivity 73.3%, 95% CI 56.5 - 90.1)(Table 4.5). The weighted score model performed 
consistently when validated using 1000 bootstrap samples.  
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4.4.3  Results for HIV/Syphilis 
 
Covariates associated with the HIV/syphilis outcome were very similar to those 
associated with HIV only. Women and MSM were more likely than other men to have 
HIV or syphilis (Table 4.2). Disease was also more likely among persons of black non-
Hispanic or Hispanic ethnicity and those in older age groups. The combined disease 
outcome was different in that it was associated with reported cocaine use (OR 1.8, 95% 
CI 0.94-3.3). 
The reference model was nearly the same as the one for HIV only but with 
cocaine use substituted for marijuana use. The model included the composite sex 
variable, age, race/ethnicity, ever tested for HIV, and cocaine use (Table 4.4). After 
backward elimination, the final model retained only the demographic variables sex, age, 
and race/ethnicity. The ROC curves for full and final models were similar (ROCref 
=0.7488, ROCfinal =0.7453, χ2 p=0.42) and the model fit the data (Hosmer-Lemeshow test 
p=0.82). 
The weighted risk scores for the HIV/syphilis model ranged from zero for a 
heterosexual man, age 18-24, with a race/ethnicity in the referent group to 7 for MSM, 
age 35 or older, and of Hispanic or Black non-Hispanic race/ethnicity (Table 4.4). The 
cutoff for screening 50% would be a score of 4 or more. This algorithm has good 
sensitivity for the detection of syphilis (80.0%, 95% CI 64.8 – 95.2) but is much weaker 
for the detection of HIV cases (sensitivity 65.2%, 95% CI 50.9 – 79.5)(Table4.5). 
Performance was validated with a bootstrapping analysis of 1000 samples. 
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4.4.4  Cost Analysis 
 
The North Carolina Syphilis Elimination Effort employed teams of two people to 
work in each participating county jail for screening. They ranged from phlebotomists 
(about $23,000 annual salary) to registered nurses (about $56,000)33. Assuming an 
average wage in the middle ($39,500), the annual salary cost for each jail program is 
~$79,000. Given constraints previously described, a screening team could be expected to 
test a maximum of 30-40 inmates per day34. Estimating 30 inmates per day, five days a 
week, each program could possibly screen 7,800 per year. These assumptions are applied 
to four HIV/syphilis screening scenarios, shown in Table 5. Costs from screening tests 
are based on Medicaid reimbursement rates and are taken from a DPH impact analysis as 
previously described32. 
The four scenarios are based on an HIV testing model with the question of 
whether or not (a) HIV screening should be universal (volunteers as available) or targeted 
(volunteers based on a screening algorithm) and (b) whether or not syphilis screening 
should be added to the HIV testing program. Because the HIV screening component is a 
given (currently the funded programs are based on HIV screening), all personnel costs are 
applied to the HIV figures. 
The cost for each scenario is dependent upon the expected number of positive 
screening tests that will require additional testing. As described above, the weighted risk 
scores for the HIV outcome model provide optimal performance in the detection of HIV 
(sensitivity 82.6%) and secondarily, syphilis (sensitivity 73.3%) (Table 4.5). When these 
risk scores are applied to a hypothetical situation in which 50% of the inmates are tested, 
the composition of the screened population has necessarily changed. The HIV and 
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syphilis prevalence in these “new” populations is by design higher than in the untargeted 
group. These targeted population prevalences for HIV (2.3%), syphilis reactive test 
(7.1%), and syphilis case (1.3%) are applied to the cost estimates for the targeted testing 
scenarios in Table 4.6. The prevalence estimates from the study data (Table 4.1) were 
applied to the universal screening scenarios in Table 4.6. This is appropriate because the 
Syphilis Elimination screening program from which the study data were collected 
employed a standard screening strategy of offering testing to all available inmates and 
screening volunteers as time permitted.  
The higher prevalence of disease in the targeted scenarios contributes to higher 
overall program cost due to the higher number of necessary confirmatory tests (from 
$238,648 to $249,579 when screening for both HIV and syphilis). However, efficiency 
increases dramatically. The number of HIV cases detected goes from 101 to 179 (increase 
of 77%) and the cost per case drops from $2,189 to $1,262, (a decrease of 42%). The 
addition of syphilis testing to this algorithm adds very little total cost ($23,707) and 
would result in the detection of 101 new syphilis cases for a cost per case of just $235.  
 
4.5  DISCUSSION 
 
Theoretically, a “universal” screening approach would mean that all people are 
screened whereas a targeted approach would have fewer persons screened. In practice, a 
similar number of inmates is likely to be screened under either approach. The jail 
screening experience in North Carolina has been that teams of two can generally screen a 
maximum of 30 inmates per day even though there are often far more than 30 new 
inmates booked in the jail per day. It is unlikely that additional staff will be hired to 
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screen more people and it is therefore desirable to target the available personnel and tests 
to those inmates most likely to have HIV infection or syphilis. The screening algorithm 
developed in this study can serve to better inform which 30 people will be screened.  
The sensitivity of the algorithm with respect to HIV is the most important factor 
in choosing which risk score method should be used. The CDC estimates that one in four 
people infected with HIV is unaware of their status. The new screening efforts, including 
jail screening, aim to notify many of these people of their HIV status so that they can 
protect their own health through treatment and protect the health of others by taking steps 
to prevent transmission25.  Poor specificity (the ability to correctly inform negative 
subjects that they are disease-free) is less of a concern and should not be used to reject a 
model with good sensitivity. Likewise, the sensitivity of the model for syphilis is 
important but remains subordinate to the need for good sensitivity for HIV. 
We therefore recommend the use of the weighted risk scores (cutoff=3) developed 
from the HIV outcome model. Sensitivity for the detection of HIV is much better than 
that for the combined outcome model (82.6% vs. 65.2%)(Table 4.5). This model also has 
quite good ability to detect new syphilis cases (sensitivity 73.3%). This algorithm has 
been converted to a screening tool that could be used in the jail setting to guide selection 
for screening (Figure 4.1). It should be noted that while the screening cutoff of 3 was 
designed to screen less than 50% of the total inmates, for the study population, the 
algorithm actually results in screening 39.2% of men and 81.0% of women (46.6% of the 
study population). This is reassuring given the heightened concerns about perinatal HIV 
transmission and congenital syphilis in this population. 
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The benefits of the targeted screening approach are enhanced when the costs are 
analyzed. As described above, the same number of inmates is likely to be screened under 
either universal or targeted testing. The issue becomes the efficiency of the screening 
approach taken. For the cost scenarios presented in Table 4.6, overall program costs go 
up slightly under targeted testing due to the higher number of confirmatory tests 
performed. However, efficiency is greatly improved with more HIV cases detected (179 
vs 101) and a lower cost per case detected ($2,189 vs. $1,262). The addition of syphilis 
testing to this scenario adds very little overall cost and would detect 101 new syphilis 
cases. We therefore recommend a targeted testing approach and testing for both HIV and 
syphilis. 
The data for this study were collected as part of Syphilis Elimination program 
evaluation activities, not as a research project. Data were only available for inmates who 
accepted the offer of syphilis (and often HIV) testing. It is possible that inmates who 
refused testing differed on important characteristics from inmates who accepted testing. It 
would be particularly important to know about refusals if the goal of the study were to 
explain the factors associated with having a positive HIV or syphilis test. However, the 
goal was to build a tool for prediction. The sample we used were inmates who voluntarily 
agreed to be tested and the tool we developed is also likely to be applied to a similar 
target population of screening volunteers.  
The fact that the screening algorithm includes race/ethnicity may make it 
politically difficult to implement. We considered this when we translated the risk scores 
to the algorithm, placing race/ethnicity last in the series of parameters (Figure 1). This 
means that most inmates will be assigned to screening or not based on other criteria. Age 
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and race/ethnicity are also pieces of information that are routinely recorded for each 
person as part of the booking process for the jails. The screener may be able to use this 
information without directly asking the person to report their race and ethnicity. Training 
of the screening personnel would have to include detailed discussion about how the 
algorithms were developed and why they are useful. It may be useful to point out that the 
CDC enhanced testing initiative under which the HIV jail screening programs are funded 
is designed specifically to address racial disparities in HIV testing25. 
Our treatment of HIV and syphilis screening costs was simplistic. We did not 
attempt to quantify certain other important fixed (overhead, office space) and variable 
(costs of treatment and sequelae) costs. Nor did we attempt to describe the savings 
associated with HIV and syphilis cases prevented. Our goal was merely to provide a 
framework for assessing the impact of universal vs. targeted screening and of adding 
syphilis screening to existing HIV testing programs. The conclusions we have drawn are 
relative and are likely to hold true, even if other costs were to be included in the 
calculations. Namely, targeted screening slightly increases overall program costs but with 
large gains in effectiveness (decreased cost per case detected). Also, the cost of adding 
syphilis screening to an already existing jail HIV screening program is very low and 
should be recommended in communities with incident syphilis cases.  
We believe that the screening algorithm will perform well in the county from 
which the sample was drawn. Generalization to other communities in the Southern 
United States with similar demographics and rates of HIV and syphilis is also possible. 
We consider it a distinct strength of the study that syphilis cases were fully diagnosed and 
staged since a large proportion of people with positive syphilis screening tests do not 
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actually have current disease. The screening tools developed here can help improve the 
efficiency of jail screening. We hope that the algorithms and the cost assessment will 
encourage communities with funding for HIV screening to consider adding syphilis 
testing to their protocols.  
 
 
 
 
 
  
109 
Table 4.1: Characteristics of Inmates screened for HIV and syphilis in North Carolina jails 2002-2005 
 
 Men 
N=2985 (82.3%) 
Women 
N=641 (17.7%) 
Total 
N=3626 
Characteristic N % N % N % 
       
STD SCREENING       
       
Screened for HIV and syphilis 2985 82.3 641 17.7 3626 100.0 
Ever tested for HIV before 1983 66.4 494 77.1 2477 68.3 
HIV positive 34 1.1 12 1.9 46 1.3 
Reactive syphilis test 99 3.3 59 9.2 158 4.4 
Confirmed new syphilis case 22 0.74 8 1.3 30 0.83 
Coinfected (HIV positive and confirmed new 
syphilis case) 
0 0 0 0 0 0 
Either disease (HIV positive or confirmed new 
syphilis case) 
56 1.9 20 3.1 76 2.1 
       
DEMOGRAPHICS       
       
Age        
  18-24 years 740 24.8 114 17.8 854 23.6 
  25-34 years 916 30.7 256 39.9 1172 32.3 
  35-44 years 916 30.7 216 33.7 1132 31.2 
  45+ years 413 13.8 55 8.6 468 12.9 
       
Race/ethnicity       
  White non-Hispanic 752 25.2 259 40.4 1011 27.9 
  Black non-Hispanic 1975 66.2 343 53.5 2318 63.9 
  Native American non-Hispanic 32 1.1 11 1.7 43 1.2 
  Hispanic  180 6.0 21 3.3 201 5.5 
  Asian/Pacific Islander non-Hispanic 22 0.74 2 0.31 24 0.66 
  Other/unknown 11 0.36 2 0.32 13 0.36 
  Missing 13 0.44 3 0.47 16 0.44 
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Table 4.1: Characteristics of Inmates screened for HIV and syphilis in North Carolina jails 2002-2005 (continued) 
 
 Men 
N=2985 (82.3%) 
Women 
N=641 (17.7%) 
Total 
N=3626 
Characteristic N % N Characteristic N % 
       
RISKS       
Homeless 70 2.4 45 7.0 115 3.2 
Men who have sex with men (MSM) 13 0.44 -- -- -- -- 
Multiple sex partners 430 14.4 134 20.9 564 15.6 
STD diagnosis 152 5.1 73 11.4 225 6.2 
Trade sex for drugs or money 131 4.4 108 16.9 239 6.6 
Alcohol use 513 17.2 161 25.1 674 18.6 
Marijuana use 328 11.0 103 16.1 431 11.9 
Injection drug use 46 1.5 32 5.0 78 2.2 
Cocaine use 205 6.9 148 23.1 353 9.7 
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Table 4.2: Odds ratios and 95% confidence intervals for the association between HIV and syphilis screening outcomes and 
predictor characteristics among inmates screened in two North Carolina jails 2002-2005 
 
  HIV positive 
N=46 
HIV positive or confirmed new syphilis case 
N=76 
Characteristic N OR (95% CI) 
Unadjusted 
p OR (95% CI) 
Adjusted 
p OR (95% CI) 
Unadjusted 
p OR (95% CI) 
Adjusted 
p 
          
Men (all others) 2972 Ref -- Ref -- Ref -- Ref -- 
Women 641 1.8  (0.92 – 3.5) 0.08 2.0  (0.98 – 4.0) 0.06 1.8  (1.1 – 3.0) 0.03 2.0  (1.2 – 3.6) 0.01 
MSM 13 28.5  (7.5 – 108.5) <0.01 38.9  (7.5 – 201.2) <0.01 16.5  (4.4 – 61.8) <0.01 21.6  (4.8 – 97.6) <0.01 
          
Ever tested for HIV  2477 2.6  (1.2 – 5.9) 0.02 2.3  (1.0 – 5.3) 0.05 1.6  (0.94 – 2.8) 0.08 1.3  (0.75 – 2.3) 0.33 
          
Age          
  18-24 years 854 Ref -- Ref -- Ref -- Ref -- 
  25-34 years 1172 2.8  (0.91 – 8.3) 0.07 2.4  (0.79 – 7.5) 0.12 3.1  (1.2 – 8.2) 0.02 2.9  (1.1 – 7.7) 0.04 
  35-44 years 1132 3.8  (1.3 – 11.2) 0.02 2.8  (0.94 – 8.6) 0.06 4.8  (1.9 – 12.3) 0.01 3.7  (1.4 – 9.8) 0.01 
  45+ years 468 3.2  (0.94 – 11.1) 0.06 2.7  (0.76 – 9.5) 0.13 7.2  (2.7 – 19.4) <0.01 6.0  (2.2 – 16.6) <0.01 
          
Race/ethnicity          
  White/all other 1091 Ref -- Ref -- Ref -- Ref -- 
  Black NH/Hispanic 2519 3.9  (1.5 – 9.9) 0.01 3.5  (1.4 – 8.9) 0.01 5.2  (2.2 – 11.9) <0.01 5.6  (2.4 – 13.1) <0.01 
          
RISKS          
Homeless 115 0.68  (0.09 – 4.9) 0.70 0.72  (0.09 – 5.9) 0.76 1.3  (0.39 – 4.1) 0. 70 1.0  (0.29 – 3.8) 0.94 
Multiple sex 
partners 
564 0.97 (0.43 – 2.2) 0.95 1.0  (0.32 – 3.1) 1.00 0.92 (0.48 – 1.8) 0.79 0.86 (0.35 – 2.2) 0.76 
STD diagnosis 225 1.1  (0.32 – 3.4) 0.93 0.74  (0.20 – 2.7) 0.65 1.3  (0.56 – 3.0) 0.54 0.84  (0.33 – 2.1) 0.72 
Trade sex for drugs 
or money 
239 0.98  (0.30 – 3.2) 0.99 0.68  (0.14 – 3.2) 0.63 1.2  (0.52 – 2.8) 0.64 0.80  (0.26 – 2.4) 0.69 
Alcohol use 674 0.92  (0.43 – 2.0) 0.83 1.1  (0.36 – 3.1) 0.82 0.90  (0.49 – 1.6) 0.74 0.75  (0.32 – 1.7) 0.50 
Marijuana use 431 0.33  (0.08 – 1.4) 0.13 0.26  (0.05 – 1.3) 0.09 0.63  (0.27 – 1.5) 0.28 0.63  (0.23 – 1.7) 0.37 
Injection drug use 78 -- -- -- -- 1.2  (0.30 – 5.1) 0.77 1.6  (0.36 – 7.5) 0.52 
Cocaine use 353 1.4  (0.59 – 3.3) 0.45 1.8  (0.53 – 6.1) 0.29 1.8  (0.94 – 3.3) 0.08 2.1  (0.85 – 5.3) 0.11 
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 Table 4.3: Odds ratios and risk scores of prevalent HIV infection by predictor characteristics among inmates screened in 
North Carolina jails 2002-2005. 
 
 Reference model 
N=3610 
ROC Area = 0.7499 
Final model 
N=3610 
ROC Area = 0.7360 
Characteristic OR (95% CI) β  (p) OR (95% CI) β  (p) Weighted Score* Unweighted Score 
       
Men (all others) Ref Ref Ref Ref 0 0 
Women 2.0  (1.0 – 4.0) 0.70  (0.05) 1.9  (0.95 – 3.7) 0.64  (0.07) 1 1 
Men who have sex 
with men (MSM) 
36.4  (8.3 – 159.4) 3.59  (<0.01) 26.0  (6.4 – 105.5) 3.26  (<0.01) 3 1 
       
Ever tested for HIV 
before 
2.4  (1.0 – 5.4) 0.86  (0.04) 2.3  (1.0 – 5.2) 0.83  (0.05) 1 1 
       
Age       
  18-24 Ref Ref Ref Ref 0 0 
  25-34 2.5  (0.80 – 7.6) 0.90  (0.12) 2.7  (0.88 – 8.3) 0.99  (0.08) 1 1 
  35-44 2.9  (0.98 – 8.7) 1.07  (0.05) 3.3  (1.1 – 9.8) 1.19  (0.03) 1 1 
  45+ 2.8  (0.79 – 9.6) 1.01  (0.11) 3.2  (0.91 – 11.0) 1.15  (0.07) 1 1 
       
Race/ethnicity       
  White/all other Ref Ref Ref Ref 0 0 
  Hispanic or   
Black/non-Hispanic 
3.5  (1.4 – 9.1) 1.26  (0.01) 3.5  (1.4 – 9.1) 1.26  (0.01) 1 1 
       
Marijuana use 0.28  (0.06 – 1.3) -1.28  (0.01) -- -- -- -- 
       
* Weighted score = β coefficient rounded to the nearest integer 
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Table 4.4: Odds ratios and risk scores of disease outcome (prevalent HIV infection or confirmed new syphilis case) by 
predictor characteristics among inmates screened in North Carolina jails 2002-2005. 
 
 Reference Model 
N=3610 
ROC Area=0.7488 
Final Model 
N=3610 
ROC Area=0.7453 
Characteristic OR (95% CI) β  (p) OR (95% CI) β  (p) Weighted Score* Unweighted Score 
       
Men (all others) Ref Ref Ref Ref 0 0 
Women 2.0  (1.1 – 3.4) 0.68  (0.02) 2.1  (1.3 – 3.6) 0.76  (0.01) 1 1 
Men who have sex 
with men (MSM) 
14.9  (3.7 – 60.0) 2.70  (<0.01) 15.8  (4.0 – 61.8) 2.76  (<0.01) 3 1 
       
Ever tested for HIV 
before 
1.3  (0.77 – 2.3) 0.29  (0.31) -- -- -- -- 
       
Age*       
  18-24 Ref Ref Ref Ref 0 0 
  25-34 3.1  (1.1 – 8.2) 1.12  (0.03) 3.2  (1.2 – 8.6) 1.16  (0.02) 1 1 
  35-44 4.2  (1.6 – 11.1) 1.44  (<0.01) 4.6  (1.8 – 11.9) 1.52  (<0.01) 2 1 
  45+ 6.9  (2.5 – 18.9) 1.93  (<0.01) 7.4  (2.7 – 20.1) 2.00  (<0.01) 2 1 
       
Race/ethnicity       
  White/all other Ref Ref Ref Ref 0 0 
  Hispanic or 
Black/non-Hispanic 
5.3  (2.3 – 12.3) 1.66  (<0.01) 5.3  (2.3 – 12.2) 1.66  (<0.01) 2 1 
       
Cocaine use 1.3  (0.68 – 2.6) 0.28  (0.41) -- -- -- -- 
       
* Weighted score = β coefficient rounded to the nearest integer 
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Table 4.5: Performance of selective screening criteria characteristics among inmates screened in North Carolina jails 2002-
2005. 
 
 HIV positive model 
N=3610 
HIV positive or confirmed new syphilis case model 
N=3610 
Outcome tested 
Scoring method 
Risk 
score 
cutoff 
Sensitivity 
95% CI 
Specificity 
95% CI 
Risk 
score 
cutoff 
Sensitivity 
95% CI 
Specificity 
95% CI 
       
HIV only       
  Predicted prob. 0.009 82.6  (71.2 – 94.0) 53.9  (52.3 – 55.5) 0.029 65.2  (50.9 – 79.5) 64.3  (62.7 – 65.8) 
  Weighted score  3 82.6  (71.2 – 94.0) 53.9  (52.3 – 55.5) 4 65.2  (50.9 – 79.5) 64.3  (62.7 – 65.8) 
  Unweighted score 3 80.4  (68.5 – 92.3) 53.9  (52.3 – 55.5) 3 23.9  (11.1 – 36.7) 91.2  (52.3 – 55.5) 
       
Syphilis only       
  Predicted prob. 0.009 73.3  (56.5 – 90.1) 53.6  (52.0 – 55.3) 0.029 80.0  (64.8 – 95.2) 64.2  (62.7 – 65.8) 
  Weighted score  3 73.3  (56.5 – 90.1) 53.6  (52.0 – 55.3) 4 80.0  (64.8 – 95.2) 64.2  (62.7 – 65.8) 
  Unweighted score 3 73.3  (56.5 – 90.1) 53.7  (52.1 – 55.3) 3 20.0  (4.8 – 35.2) 91.1  (90.2 – 92.0) 
       
HIV or syphilis       
  Predicted prob. 0.009 79.0  (69.6 – 88.3) 54.1  (52.5 – 55.8) .029 71.1  (60.6 – 81.5) 64.6  (63.0 – 66.2) 
  Weighted score  3 79.0  (69.6 – 88.3) 54.1  (52.5 – 55.8) 4 71.1  (60.6 – 81.5) 64.0  (63.0 – 66.2) 
  Unweighted score 3 77.6  (68.1 – 87.2) 54.1  (52.5 – 55.8) 3 22.4 (12.8 – 32.0) 91.3  (90.4 – 92.2) 
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Table 4.6: Costs of Screening for Syphilis and HIV in jail settings under four screening strategy scenarios 
 
 Universal screening* 
 
Targeted screening ** 
 Screen for HIV only Screen for HIV and syphilis Screen for HIV only Screen for HIV and syphilis 
ASSUMPTIONS     
Individuals to be screened 7800 7800 7800 7800 
HIV case prevalence 101  (1.3%) 101  (1.3%) 179  (2.3%) 179  (2.3%) 
Syphilis screen prevalence 
(reactive screening test rate) 
-- 343  (4.4%) -- 554  (7.1%) 
Syphilis case prevalence 
(confirmed cases) 
-- 65  (0.83%) -- 101  (1.3%) 
HIV screening tests (EIA) 7800 7800 7800 7800 
HIV confirmatory tests (WB) 
(HIV prevalence * 7800) 
101 101 179 179 
Syphilis screening tests -- 7800 -- 7800 
Syphilis quantitative tests 
(Syphilis screen prevalence * 
7800) 
-- 343 -- 554 
Syphilis confirmatory tests 
(Syphilis screen prevalence * 
7800) 
-- 343 -- 554 
     
continued 
  
116 
Table 4.6: Costs of Screening for Syphilis and HIV in jail settings under four screening strategy scenarios 
 
 Universal screening* 
 
Targeted screening ** 
 Screen for HIV only Screen for HIV and syphilis Screen for HIV only Screen for HIV and syphilis 
COSTS     
Personnel (2 employees) $79,000 $79,000 $79,000 $79,000 
HIV screening tests ($17.41 
per EIA test) 
$135,798 $135,798 $135,798 $135,798 
HIV confirmatory tests 
($17.41 x 2 repeat EIA and 
$27.05 per WB test) 
$6,249 $6,249 $11,074 $11,074 
Syphilis screening ($0.98 per 
stat RPR screening test) 
$0 $7,644 $0 $7,644 
Syphilis confirmatory tests 
($6.22 per quantitative RPR  
test and $22.81 per 
confirmatory test – MHATP 
or FTA-ABS) 
$0 $9,957 $0 $16,083 
Total program cost $221,047 $238,648 $225,872 $249,579 
     
Cost/HIV case detected 
(cases/(personnel + HIV 
testing costs)) 
$2,189 $2,189 $1,262 $1,262 
Cost/syphilis case detected 
(cases/syphilis testing costs) 
-- $271 -- $235 
     
* Universal screening = volunteers on a first come basis. Disease prevalence estimates taken from study population (Table 1).  
** Targeted screening = volunteers from screening algorithm based on weighted risk scores from the model for HIV infection only 
(Table 4). Disease prevalence estimates taken from populations that would be screened if selected using those risk scores. 
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Figure 4.1: Algorithm for screening jail inmates for HIV infection 
 
SEX  MSM  EVER HIV 
TESTED 
 AGE  RACE  SCREEN 
           
Male  (0) 
 
 Yes  (3)        Screen 
  No  (0)  Yes  (1)  25+  (1)  Hispanic or black non-
Hispanic  (1) 
 Screen 
    No  (0) 
Stop – do 
not screen 
 18-24 (0) 
Stop – do not 
screen 
 White/all other races  (0) 
Stop – do not screen 
  
           
Female (1) 
 
   Yes  (1)  25+  (1)    Screen 
      18-24  (0)  Hispanic or black non-
Hispanic  (1) 
 Screen 
        White/all other races  (0) 
Stop – do not screen 
  
    No  (0)  25+  (1) 
 
    
      18-24  (0) 
Stop – do not 
screen 
 Hispanic or black non-
Hispanic  (1) 
 Screen 
        White/all other races  (0) 
Stop – do not screen 
  
           
Screening algorithm applies weighted risk scores from the model predicting HIV infection to the hypothetical scenario of screening 
<50% of the jail population. The individual score for each attribute is listed in parentheses to the right. A cumulative score of 3 or 
more directs individuals to screening. Those with scores of 2 or less should not be screened. 
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5.1  SCOPE OF THE PROBLEM  
 
This dissertation sought to improve the efficiency of jail screening for syphilis 
and HIV through the development of algorithms for targeted screening and the 
examination of program costs. 
North Carolina is a state disproportionately affected by both syphilis and HIV. 
From 1993-2003, North Carolina ranked in the top 10 states in primary and secondary 
syphilis rates and in the top 20 for congenital syphilis rates. When the NC primary & 
secondary syphilis rate peaked in 1992, it was nearly three times higher than the national 
rate that year (36.2 vs. 13.3/100,000)1.  This coincided with the state’s HIV epidemic. 
New HIV disease (first report of HIV infection) reports in North Carolina were highest 
from 1992-1995, averaging over 2000 reports per year2. Syphilis also disproportionately 
affects minority populations in North Carolina. The vast majority of HIV disease and 
early syphilis cases were among non-Hispanic blacks (approximately 70% per year, 
2000-2006) though they make up only 22% of the State’s population2. 
When the Centers for Disease Control and Prevention (CDC) launched its 
Syphilis Elimination Effort (SEE) in 1999, five of the 28 funded counties were in North 
Carolina. In the 1999 publication “The National Plan to Eliminate Syphilis from the 
United States”3, the CDC outlined the rationale for undertaking something so ambitious.  
The elimination of syphilis was deemed important for two major reasons: to reduce 
racial/ethnic health disparities and because syphilis infection may contribute to the 
transmission of HIV.  
One of the many strategies recommended by CDC was screening of jail inmates 
for both syphilis and HIV. All six SEE counties (one was added later) in North Carolina 
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participated in this effort, though only one added the HIV screening component. To 
ensure access to inmates before they are able to post bond (half will do so within two 
days of arrest4), screening took place at intake whenever possible. Most of the time, 
screening was done by teams of two, one to interview inmates and complete paperwork 
and one to draw blood samples for testing. Despite these best efforts, most of the 
participating jails screened less than 10% of the total inmates booked into the jail5.  While 
it may be possible to improve this percentage with some operational changes, the bottom 
line is that the resources do not currently exist to screen all of the inmates in the SEE 
county jails for syphilis and HIV.  
The Syphilis Elimination Effort was a success in many ways. Primary and 
secondary syphilis rates dropped steeply. With this came dramatic reductions in funding6. 
In North Carolina, nearly all of the jail screening staff positions were lost in these cuts. 
Fortunately, the CDC launched another new initiative, this one regarding the expansion 
of HIV testing, including jail screening7. The end result has been that the former syphilis 
jail screening projects were converted to HIV screening projects. This dissertation sought 
to address the issue of the continued relevance of syphilis screening in this new 
environment. This was done through the development of targeted screening algorithms 
and the assessment of program costs. 
The identification of previously undiagnosed syphilis and HIV cases through jail 
screening has benefits at several levels. It is estimated that one in four people infected 
with HIV is unaware of their status7.  Knowledge of HIV infection can help people 
protect their own health through treatment and protect the health of others by taking steps 
to prevent transmission.  This is particularly true for pregnant women since treatment can 
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dramatically reduce perinatal transmission8. Identification and treatment of early syphilis 
cases also reduces transmission and helps control outbreaks. When late cases are 
diagnosed, the primary benefit is to the patient in the prevention of serious sequelae of 
late syphilis. Because women can transmit syphilis to their infants in utero up to eight 
years past the initial date of their own infection, finding female syphilis cases at any stage 
is critical to the prevention of congenital syphilis cases9, 10.  
 
5.2  FINDINGS 
 
Screening algorithms with good sensitivity were produced for both syphilis and 
HIV. In the first study, syphilis screening data from all seven jails was modeled to create 
weighted risk scores and a screening algorithm for predicting new syphilis cases in men. 
The model included age, race/ethnicity, and reporting an STD diagnosis in the last six 
months and the resulting algorithm had a sensitivity of 82.7%. The same data did not 
yield a useful model for predicting syphilis in women. After model reduction, only 
cocaine use was retained in the final model and this single predictor was not effective for 
predicting new syphilis cases among female jail inmates (sensitivity 64.9%). 
The second study sought to address the new programmatic changes in NC jail 
screening by focusing on screening for HIV. To address the issue of small cell sizes and 
the different outcome, a single model for both male and female inmates was developed. 
The final model contained sex, age, race/ethnicity and history of HIV testing and the 
resulting algorithm had sensitivity of 82.6% for the detection of HIV and 73.3% for the 
detection of syphilis. 
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The model results of the second study were applied to cost scenarios for universal 
vs. targeted screening for HIV only and HIV plus syphilis. Costs were compared under 
the assumption that that the same number of inmates would be screened under non-
targeted vs. targeted selection. Targeted screening resulted in higher overall cost due to 
the larger number of confirmatory tests required. Selective screening improved efficiency 
in terms of the number of cases detected (increase 77% under targeted screening) and the 
cost per case detected (42% lower under targeted screening).   
Both studies make major contributions to the jail screening literature by filling in 
gaps in both geography and epidemiology. For this dissertation, a comprehensive review 
of the literature was conducted. Nineteen studies11-29 in which incarcerated subjects were 
screened for syphilis and 13 in which subjects were screened for HIV11-14, 18, 19, 22, 28, 30-34 
were identified (Appendix A and Appendix B). Of the nineteen syphilis studies, only 3 
used a complete case diagnosis approach to measuring syphilis as was done here. Only 
six studies included information on risk behaviors and just six included facilities located 
in southern states. Among the thirteen HIV studies, only three were conducted in the 
southeast. Our study is the only one to apply screening results to a cost analysis.   
 
5.3  LIMITATIONS 
 
Because the data were collected as part of health department program evaluation 
activities and not as part of a research project, no provision was made to track those who 
were offered syphilis testing but refused. There was, however, data to show that over 
98% of inmates who were offered HIV testing did accept it, among persons who had 
already agreed to be tested for syphilis. It is certainly possible that inmates who refused 
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syphilis testing were different from those who accepted which could bias our descriptive 
results. However, our main goal was to develop algorithms for use in future jail 
screening. Our study sample included volunteers who accepted the offer of testing. The 
population to which the screening algorithm would be applied would also be volunteers, 
minimizing the impact of possible bias.  
Likewise, there is no way to know how truthful the respondents are regarding the 
self-reported behavioral risks. If the goal was to explain the role of these risks in 
predicting infection, this would be a valid concern. However, when the risk algorithms 
are applied in the field, risk behaviors reported will be self-reported. It is therefore 
reasonable to base the algorithm on data collected in the same fashion.  
The cost assessment performed was by design, simplistic. A full accounting of 
fixed and variable costs of the screening program scenarios was not attempted. The goal 
was to examine the relationships between universal and targeted screening and of adding 
syphilis screening to existing HIV testing programs. While the true cost per HIV case 
diagnosed might not be exactly as we have calculated, we expect that the relative position 
of this cost when compared to another scenario would remain the same. 
The most serious concern to emerge from the studies presented here is the issue of 
using race/ethnicity as a screening criterion. Incarcerated populations and persons with 
sexually transmitted diseases are already marginalized groups. Adding race to the 
equation may prove too sensitive to implement. County syphilis rates were examined as a 
possible substitute for race/ethnicity in the syphilis predictive model. Unfortunately, the 
performance of the resulting screening algorithm was substantially inferior to the 
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algorithm derived from the model that incuded race/ethnicity (sensitivity (73.4% vs. 
82.7%).  
Despite the possible problems associated with race/ethnicity as screening criteria, 
we recommend the use of the HIV and syphilis screening algorithms developed here. One 
way to address the issue is to structure the algorithm such that the subject is somewhat 
shielded from the knowledge that race/ethnicity is playing a role in selection for 
screening by incorporating data already collected by the jail booking process and/or 
placing race/ethnicity last in the list of criteria for screening. In either case, those 
implementing the protocol will be aware that race/ethnicity is part of the screening 
process. The rationale for using the criteria should be well covered in employee training, 
and should mention that both Syphilis Elimination and the expanded HIV testing 
programs were conceived by CDC specifically to address racial disparities in STDs3, 7.  
 
5.4  NEXT STEPS 
 
The findings from this dissertation are of direct benefit and use to the jail 
screening programs operated by the North Carolina Division of Public Health. The 
screening algorithms will likely perform well in the counties from which the samples 
were drawn. The SEE counties had high syphilis rates when they were chosen for 
Syphilis Elimination in 1999. Generalization to other counties with much lower rates of 
syphilis may be more problematic. It is reasonable to expect that the algorithms may 
translate well to jail screening programs in other high prevalence counties in the 
Southeast where inmate demographics may be similar.  
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Due to the changes in the CDC funding climate, HIV screening may become the 
norm for jails that conduct any STD screening. If so, the syphilis screening algorithm for 
men may be a bit too late to arrive on the scene although it has the advantage of having 
been based on a much larger sample from six counties. It is therefore anticipated that the 
algorithm built from the model for HIV infection will be of the most interest to jail 
screening programs seeking to improve the efficiency of their screening efforts. 
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SYPHILIS SCREENING STUDIES 
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Appendix A: Summary of syphilis screening studies in incarcerated US adults (n=19) 
 
Author, 
Year, Ref 
Data 
year(s) 
Location Facility Gender, n Syphilis case 
definition 
Syphilis % Other 
outcome 
measures 
Behav. 
risks 
Arrest 
Info 
Notes 
Altice, 
(2005)1 
1994-
1996 
CT Jail/ 
Prison 
combo 
F 
(3,315) 
RPR+, confirm 
FTA-ABS +, 
Self report 
Serology 
(6.2%) 
Self report 
(8.5%) 
HIV (7.5%) 
Other STDs by 
self report 
Yes 
 
Assoc 
w. HIV 
 
 
No Syphilis assoc 
w. HIV+ status: 
Serology 
OR 3.2  
(2.1-5.0) 
Self report 
OR 2.2  
(1.5-3.3) 
De Ravello, 
(2005)2 
1998-
1999 
GA Prison F 
(3,636) 
RPR≥1:8, 
confirm FTA-
ABS + 
RPR+ 
(9.7%) 
RPR≥1:8 
(2.6%) 
HIV (4.0%) 
Gc (0.7%) 
Ct (5.9%) 
Trich (8.2%) 
TB (10.5%) 
Pregnant 
(4.3%) 
No No Retrospective 
chart abstraction 
Solomon, 
(2004)3 
2002 Baltimore 
MD 
Jail and 
Prison 
M 
(3,343) 
F 
(571) 
RPR+, confirm 
FTA-ABS + 
Jail (0.1%) 
Prison 
(1.8%) 
Jail 
HIV (7.4%) 
HCV (31.1%) 
HBV (11.4%) 
 
Limited 
 
Assoc 
w. HCV 
Limited  
Jail: 
46.1% 
drug 
charge 
Prison: 
28.9% 
Main focus HCV 
screening 
Chen, 
(2002)4 
2000 Los 
Angeles 
CA 
Jail M 
(811) 
all MSM 
Full case 
diagnosis & 
staging. 
New vs. 
previously 
treated 
New (1.1%) 
Prev Tx 
(3.6%) 
HIV (9.0%) 
Ct (2.5%) 
Gc (0.9%) 
 
 
Limited 
 
Prevale
nce 
only 
No Screening in 
section of jail 
housing self-
identified MSM 
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Author, 
Year, Ref 
Data 
year(s) 
Location Facility Gender, n Syphilis case 
definition 
Syphilis % Other 
outcome 
measures 
Behav. 
risks 
Arrest 
Info 
Notes 
Finelli, 
(2002)5 
1996-
1999 
LA, MS, 
SC, TX 
Jails M 
(67,756) 
F 
(12,202) 
RPR+,  
RPR≥1:8 
M 
RPR+ 
(5.2%) 
RPR≥1:8 
(1.9%) 
F 
RPR+ 
(11.1%) 
RPR≥1:8 
(4.1%) 
None No No Reported P&S 
syphilis case 
rates in 
community 
compared to % 
RPR≥1:8 
No  strong 
assoc. 
 
Kahn, 
(2002)6 
1994-
1998 
Baton 
Rouge, LA 
Jail M 
(32,573) 
F 
(6,156) 
RPR+, confirm 
VDRL+, 
MHATP+, Tx 
and interview if 
available for 
staging 
M (1.1%) 
F (2.5%) 
 
None No Yes 
 
See 
notes 
Nested case 
control to 
examine arrest 
info (n=165) 
M: 
Felony theft 
OR 4.3 
(1.5-13.6) 
F:  
Prostitution  
OR 7.0  
(1.5-39.3) 
Mertz, 
(2002)7 
1996-
1999 
AL, AZ, 
CA, GA, 
IL, MA, 
NY, RI 
Jails 
(n=23) 
M 
Range 
(3,560-
94,137) 
F 
Range 
(512-
13,741) 
 
RPR+,  
RPR≥1:8 
Median, 
range 
M 
RPR+ 
2.5 % 
(1.0-7.8) 
RPR≥1:8 
0.6% 
(0.1-2.9) 
F 
RPR+ 
8.2 % 
(0.3-23.8) 
RPR≥1:8 
1.7% 
(0.0-7.4) 
None No No Also screened 
for Ct, Gc in 
juvenile facilities 
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Author, 
Year, Ref 
Data 
year(s) 
Location Facility Gender, n Syphilis case 
definition 
Syphilis % Other 
outcome 
measures 
Behav. 
risks 
Arrest 
Info 
Notes 
Arriola, 
(2001)8 
2000 FL Jails M, F 
(918) 
No information 
provided, 
assume RPR+, 
possibly with 
confirmatory 
Positive 
2.0% 
Ct [screen in 
GA, MA] 
(6.5%) 
Gc [screen in 
GA] 
(3.1%) 
HIV [screen in 
FL, NJ, NY] 
(16.8%) 
No No  
Rich, 
(2001)9 
1992-
1998 
RI Jail/ 
Prison 
combo 
F 
(6,249) 
RPR+, confirm  
FTA-ABS+ 
Tx and 
interview if 
available for 
staging 
New staged 
cases  1.4% 
HIV+ assoc 
with new 
syphilis case  
OR 2.7 (p=.04) 
Yes 
Hx STD  
OR 5.3 
(p<.01) 
Hx IDU 
OR 2.3 
(p=.04) 
 
Yes 
Drug 
charge 
OR 2.6 
(p<.01) 
SexDM 
chg 
Nested case 
control study to 
look at 
behavioral risks, 
arrest info, n= 
258 
Silberstein 
(2000)10 
1993-
1995 
Long 
Island, NY 
Jail M 
(16,690) 
F 
(1,752) 
RPR+, confirm  
FTA-ABS+, Tx 
history if 
available 
M  
RPR+ 
(2.6%) 
New case 
(1.1%) 
F  
RPR+ 
(9.4%) 
New case 
( 3.8%) 
None No No Cost benefit 
study of 
screening 
program 
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Author, 
Year, Ref 
Data 
year(s) 
Location Facility Gender, n Syphilis case 
definition 
Syphilis % Other 
outcome 
measures 
Behav. 
risks 
Arrest 
Info 
Notes 
Blank, 
(1999)11 
1993-
1997 
New York, 
NY 
Jail F 
(3,579) 
If no syph Hx 
at baseline: 
RPR+, confirm  
MHATP+ 
If syph Hx at 
baseline: 
Titer increase 
of ≥2 dilutions 
≥1 month after 
adequate Tx 
Incidence 
rate 
6.5/ 100,000 
person-
years 
 
289 of 3,579 
women 
(8.1%) 
None No No Cohort study of 
women with 
multiple jail 
admissions, 
incident syphilis 
 
Women RPR+ at 
baseline were 
more likely to 
have new 
infection 
OR 1.5  
(1.2-1.9) 
Altice, 
(1998)12 
1993 CT Prison M 
(975) 
RPR+, confirm  
FTA-ABS+, 
M 4.2% HIV (6.1%) Yes 
(assoc 
w. HIV) 
Limited Syphilis assoc. 
with HIV+ status  
serology 
OR 4.5  
(1.8-10.8) 
self-report 
OR 7.6  
(3.3-12.1) 
Blank, 
(1997)13 
1993 New York, 
NY 
Jail F 
(727) 
RPR+, Tx 
history from 
Health Dept 
record search 
Vs. 
RPR+, confirm 
MHATP+ 
Need Tx 
22.7% 
 
New cases 
15.8% 
 
None No No Evaluation of 
treatment 
protocols 
 
Stat RPR+ alone 
was similar to 
standard 
Beltrami, 
(1997)14 
1993 New 
Orleans, 
LA 
Jail M 
(4,105) 
F 
(652) 
RPR+, confirm 
MHATP+, 
VDRL+ 
M 1.5% 
F 3.1% 
LET 
M 13% 
Yes, 
prevale
nce 
only 
Limited  
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Author, 
Year, Ref 
Data 
year(s) 
Location Facility Gender, n Syphilis case 
definition 
Syphilis % Other 
outcome 
measures 
Behav. 
risks 
Arrest 
Info 
Notes 
Heimberger 
(1993)15 
1989-
1990 
Long 
Island, NY 
Jail M, F 
(9,797) 
Full case dx 
and staging 
 
ART+, confirm 
FTA-ABS+, Tx 
history from 
Health Dept 
record search 
ART+ and 
FTA-ABS+ 
2.5% 
 
New cases 
1.7% 
None No No Nested case 
control (n=481) 
 
New syph cases 
Female 
OR 5.8  
(3.4-10.0) 
Black race 
OR 4.6 
(2.7-8.1) 
Cohen, 
(1992)16 
1989 Los 
Angeles, 
CA 
Jail M 
(6,214) 
Full case dx 
and staging 
 
RPR+, confirm 
MHATP+ and 
VDRL, 
physical exam, 
patient 
interview, tx 
history from 
Health Dept 
record search 
RPR+ 
4.9% 
 
New case 
2.1% 
None Yes 
 
See 
notes 
Yes 
 
No 
assoc 
w. 
syphilis 
≥3 Sex PN 
OR 3.5  
(1.5-8.3) 
Crack cocaine 
OR 2.1  
(1.2-3.7) 
Hx Syph 
OR 2.2 
(1.0-4.7) 
Hx STD 
OR 1.7  
(1.1-2.6) 
Age, Race 
Bickell, 
(1991)17 
1988 New York, 
NY 
Jail F 
(114) 
RPR+, confirm 
FTA-ABS + 
Serology 
22.2% 
HPV (35.1%) 
Gc (7.2%) 
 
No No  
Weisfuse, 
(1991)18 
1989 New York, 
NY 
Jail M 
(1,690) 
F 
(546) 
RPR+, confirm 
MHATP+ 
M 
RPR+ 
(9.8%) 
confirmed 
(5.7%) 
F 
RPR+ 
(24.0%) 
confirmed 
(19.8%) 
M 
HIV+ (16.1%) 
F 
HIV+ (25.8%) 
Yes 
 
Assoc 
w. HIV 
No Syphilis assoc 
w. HIV+ status: 
M 
OR 2.1  
(1.6-5.8) 
F 
OR 2.0 
(1.3-5.4) 
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Author, 
Year, Ref 
Data 
year(s) 
Location Facility Gender, n Syphilis case 
definition 
Syphilis % Other 
outcome 
measures 
Behav. 
risks 
Arrest 
Info 
Notes 
Farley, 
(1990)19 
1983-
1988 
CT Jail/ 
Prison 
combo 
F 
(9,923) 
 
RPR or 
VDRL+, 
confirm FTA-
ABS+, clinical 
diagnosis 
1983 
(1.3%) 
 
1988 
(5.4%) 
None No Yes 
 
See 
notes 
Among women 
incarcerated for 
Sex DM 
(n=461), syphilis 
10%,  
Among women 
incarcerated for 
drug charges 
(n=113), syphilis 
7% 
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Appendix B: Summary of HIV screening studies in incarcerated US adults (n=13) 
 
Author, Year, 
Ref 
Data 
year(s) 
Location Facility Gender, n HIV % Other outcome 
measures 
Behav. risks Arrest Info Notes 
MacGowan 
(2007) 1 
2003-
2006 
FL, LA, 
NY, WI 
Jail M 
(26,294) 
F 
(6,916) 
M 
(0.8%) 
F 
(1.0%) 
None M 
MSMIDU, IDU, 
MSM, Risky 
partner, No Risk 
F 
Risky Partner 
No Rapid HIV 
testing 
Altice, (2005)2 1994-
1996 
CT Jail/ 
Prison 
combo 
F 
(3,315) 
(7.5%) 
 
Syphilis 
Serology (6.2%) 
Self report (8.5%) 
IDU 
OR 5.9 (3.6-9.7) 
Herpes self report 
OR 3.1 (1.7-5.5) 
CSW 
OR 3.1 (2.4-4.0) 
Sex w. IDU 
OR 3.4 (2.2-5.2) 
more 
No Syphilis assoc 
w. HIV+ status: 
Serology 
OR 3.2  
(2.1-5.0) 
Self report 
OR 2.2  
(1.5-3.3) 
De Ravello, 
(2005)3 
1998-
1999 
GA Prison F 
(3,636) 
(4.0) Syph (2.6%) 
Gc (0.7%) 
Ct (5.9%) 
Trich (8.2%) 
TB (10.5%) 
Pregnant (4.3%) 
No No Retrospective 
chart abstraction 
Macalino 
(2004)4 
1998-
2000 
RI Prison M 
(3,932) 
(1.8%) HBV (20.2%) 
HCV (23.1%) 
IDU 
OR 10.1 (6.0-17.0) 
Limited 
Recidivism (no 
assoc. with 
HIV) 
Nested HBV, 
HCV incidence 
study. 
Solomon, 
(2004)5 
2002 Baltimore 
MD 
Jail and 
Prison 
M 
(3,343) 
F 
(571) 
(7.4%) Jail 
Syph (0.1%) 
HCV (31.1%) 
HBV (11.4%) 
 
Limited 
 
Assoc w. HCV 
Limited  
Jail: 46.1% 
drug charge 
Prison: 28.9% 
Main focus HCV 
screening 
Chen, (2002)6 2000 Los 
Angeles 
CA 
Jail M 
(811) 
all MSM 
(9.0%) 
 
Syph (1.1%) 
Ct (2.5%) 
Gc (0.9%) 
 
 
Limited 
 
Prevalence only 
No Screening in 
section of jail 
housing self-
identified MSM 
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Author, Year, 
Ref 
Data 
year(s) 
Location Facility Gender, n HIV % Other outcome 
measures 
Behav. risks Arrest Info Notes 
Arriola, 
(2001)7 
2000 FL, NJ, 
NY 
Jails M, F 
(1,020) 
(16.8%) Syphilis [screen in 
FL] 
(2.0%) 
Ct [screen in GA, 
MA] 
(6.5%) 
Gc [screen in GA] 
(3.1%) 
No No  
Kassira, 
(2001)8 
1998 MD Prison M 
(4,613) 
F 
(670) 
M 
(3.1%) 
F 
(4.6%) 
None % of prison HIV 
cases 
M  
IDU (64%) 
Hetero (37%) 
F 
IDU (69%) 
Hetero (31%) 
No MSM only 1% of 
male prison HIV 
cases 
Rich, (2001)9 1992-
1998 
RI Jail/ 
Prison 
combo 
F 
(6,249) 
Not 
provided 
Syph (1.4%) 
 
HIV+ assoc with 
new syphilis case  
OR 2.7 (p=.04) 
Yes 
 
Assoc w. Syphilis 
 
Yes 
 
Assoc w. 
Syphilis  
Nested case 
control study to 
look at 
behavioral risks, 
arrest info, n= 
258 
Sabin, 
(2001)10 
1992-
1998 
US Jails  
and 
Prisons 
M 
(344,085) 
F 
(113,494) 
M 
New 
(1.9%) 
Prevalent 
(3.3%) 
F 
New 
(2.1%) 
Prevalent 
(3.8%) 
 
None As % of testers and 
% of positives. 
 
IDU 
MSM 
MSM/IDU 
No CDC counseling 
and testing data 
from US 
correctional 
facilities. 
Thiede, 
(2001)11 
1998-
1999 
Seattle, 
WA 
Jail M 
(262) 
F 
(86) 
(2.3%) None Yes 
 
Lots of IDU detail 
Prevalences only 
Yes 
 
Prevalence 
only 
Newly arrested 
IDUs only. 
Primarily a 
behavioral 
survey 
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Author, Year, 
Ref 
Data 
year(s) 
Location Facility Gender, n HIV % Other outcome 
measures 
Behav. risks Arrest Info Notes 
Altice, 
(1998)12 
1993 CT Prison M 
(975) 
(6.1%) Syph (4.2%) 
 
Hx STD 
OR 2.4 (1.3-4.3) 
Mult PN 
OR 3.1 (1.6-6.2) 
Crack 
OR 4.4 (1.3-15.4) 
IDU 
OR 16.7 (6.1-45.5) 
more 
L imited Syphilis assoc. 
with HIV+ status  
serology 
OR 4.5  
(1.8-10.8) 
self-report 
OR 7.6  
(3.3-12.1) 
Weisfuse, 
(1991)13 
1989 New York, 
NY 
Jail M 
(1,690) 
F 
(546) 
M 
(16.1%) 
F 
(25.8%) 
 
 
M 
Syph (5.7%) 
F 
Syph (19.8%) 
M 
Heroin use 
OR 3.9 (1.4-11.0) 
F 
Heroin use 
OR 7.8 (2.8-21.7) 
No Syphilis assoc 
w. HIV+ status: 
M 
OR 2.1  
(1.6-5.8) 
F 
OR 2.0 
(1.3-5.4) 
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